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1. INTRODUCTION 
1.1. The Epigenome 
1.1.1. History and Definition 
The term epigenetic was defined differently over time according to the development of 
epigenetic science. It was first used in the 1940s by the developmental biologist Conrad 
Waddington to explain “the interactions of genes with their environment, which bring the 
phenotype into being”. In the 1970s chemical DNA modifications were proposed to elucidate 
Waddington’s hypothesis. Several years later the heritable nature of epigenetic mechanisms 
was described. Since the 1990s epigenetic is defined as changes in gene expression that 
occur without a change in DNA sequence. This altered gene expression is often heritable. 
(Dolinoy et al., 2007) These changes occur via several mechanisms, which will be presented 
in the following. 
1.1.2. DNA methylation 
The adherence of a methyl group to the DNA can only occur on specific sites. These loci are 
cytosines followed by a guanine in the DNA sequence. On this so called CpG-sites methyl 
groups can be transferred enzymatically from the methyl-group-donor S-
adenoslymethionine (SAM) to the carbon-5 position of the cytosine ring (figure 1). The 
resulting 5-methylcytosine has an altered steric requirement of space than cytosine and 
because of that acts as an fifth base with different functional characteristics. This 
modification occurs after DNA-replication. The methyl group extends into the major groove 
of DNA and several ways are known by which cytosine methylation can regulate gene 
expression. 5-methylcytosine can inhibit or hinder the association of some transcriptional 
factors with their cognate DNA recognition sequences. Another mechanism is the binding of 
methyl-CpG-binding domain proteins (MBDs) to methylated cytosines mediating a repressive 
signal. MBDs can interact with chromatin forming proteins modifying surrounding 
chromatin, linking DNA methylation with chromatin modification. (Grafi et al., 2007) These 
interferences lead to an altered (mostly inhibited) transcription of the affected gene. 
INTRODUCTION 12 
 
CpG dinucleotides are underrepresented in the human genome and their appearance does 
not accord with the random distribution of other nucleotides. This could be explained by the 
evolutionary spontaneous deamination of 5-
methylcytosine to thymine (figure 1) CpG-islands, 
defined as regions containing 50 % or more CpG 
content and a length of 500 to 2000 base pairs, are 
often located within or near gene promoters or 
first exons of housekeeping genes. CpGs in CpG-
islands are predominantly unmethylated and can 
be found in half of all human genes. (Agrawal et 
al., 2007; Dolinoy et al., 2007) A global 
hypermethylation usually leads to a silencing of the affected gene but many exceptions of 
this generalization are known by now. An increased methylation on certain CpGs with a 
regulatory effect could raise gene expression and a hypomethylation on other CpGs can be 
responsible for an over expression of a gene even though a global hypermethylation exists. 
(Kim, 2004b) 
The role of the majority of all methylated CpGs is host defense against transposons which 
are rich in CpGs. (Bestor, 2000) Transposons are small repeating DNA sequences which could 
move within the genome of a cell between different genes. (Geurts et al., 2003) Transcripted 
transposons interfere with the regulation of the expression of the host gene and destabilize 
the genome through insertion and recombination. Due to the repressive effect of cytosine 
methylation the expression of the transposons is inhibited. The conversion from 5-
methylcytosine to thymine provides long-term protection against transposition by 
permanent inactivation through sequence alteration. 
Most dividing cells express DNA methyltransferases (DNMTs), which are responsible for DNA 
methylation at position five of cytosines. Mammalian DNMTs can be divided into two 
general classes. The DNMT1 enzyme is responsible for the maintenance of global 
methylation patterns on DNA. It preferentially methylates CpGs on hemimethylated DNA 
(CpG methylation on one of both DNA strands), therefore guaranteeing transfer of 
methylation marks through the cell cycle in eukaryotic cells. The DNMT1 enzyme is directly 
incorporated in the DNA replication complex. The de novo methyltransferases DNMT3a and 
DNMT3b establish methylation patterns at previously unmethylated CpGs. These enzymes 
Figure 1: Correlation between Cytosine, 5-
Methylcytosine, Uracil, and Thymidine (Bryan 
et al., 2008) 
13 INTRODUCTION 
 
seem to act only on specific loci on the genome. But the mammalian DNMTs are not 
sequence specific and thus a strict separation of their functions is not possible. It was shown 
that DNMT1 is also involved in de novo methylation. DNMT3L is a DNMT related enzyme, 
which associates with DNMT3a/3b. It influences its enzymatic activity while lacking one of its 
own. Finally, for the DNMT2 enzyme a biological function in mammals remains to be 
demonstrated. A role in some aspects of centromer function seems possible. (Bestor, 2000) 
1.1.3. Histone modification 
The principle structure of a nucleosome core particle contains a histone octamer, two copies 
of each H2A, H2B, H3 and H4 and 146 base pairs of DNA wrapped around. This arrangement 
forms a highly conserved structure which is the same in nearly all eukaryotes. But the 
possibilities of posttranslational histone modifications lead to an enormous variability of 
these conserved formation – the so called “histone code”. These modifications take place on 
the N-terminal tails of the histone-protein, which are exposed on the nucleosome surface. 
(Turner, 2000) Modifications can be (mono-, di-, and tri-) methylation, acetylation, 
phosphorylation, 
ubiquitination, ADP-
ribosylation, 
hydroxylation, 
glycosylation and others. 
Adherence of the listed 
groups can take place on 
the amino acid residues 
of serine, lysine, arginine, histidine, glutamic acid, proline, and threonine. (Delage and 
Dashwood, 2008; Turner, 2000) 
The resulting modified nucleosome can cause a shift in gene expression if modifications 
occur on a regulatory region, e.g. the promoter region. Through modifications the affinity of 
the histone proteins to the DNA is loosened or tightened depending on the modification. 
This means that the packing of the chromatin becomes either more or less dense and 
Euchromatin is shifted to heterochromatin or vice versa. Transcription factors and other for 
important mechanisms for gene expression can only work if the chromatin packing allows 
Figure 2: Nucleosomes and histone modifications (Nature Publishing Group) 
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their binding. A shift from eu- to heterochromatin thus leads to an alteration of gene 
expression. 
Histone acetylation is normally associated with an increase in gene expression because 
chromatin packaging is relaxed. The effect of histone methylation cannot easily be predicted 
because it depends on the kind of histone and the amino acid residue modified. (Dolinoy et 
al., 2007) An overview of the functions of histone modifications is given in table 1. 
 
Histone Modification Effect 
H1  Phosphorylation Chromatin condensation, gene 
specific condensation and repression. 
 Ubiquitination Transcriptional activation 
H2A Acetylation Transcriptional activation 
 Ubiquitination Elusive 
H2B Ubiquitination Prerequisite of H3 methylation 
 Phosphorylation Chromatin condensation 
 Acetylation Chromatin remodeling 
 Methylation Chromatin stabilization 
H3 Methylation (H3-K4, R17) Transcriptional activation 
 Methylation (H3-K9, K79) Transcriptional repression 
 Acetylation Transcriptional activation 
 Phosphorylation Chromatin condensation; 
transcriptional activation 
 Ubiquitination Nucleosome loosening 
H4  Acetylation Transcriptional activation 
 Methylation (H4-K20) Transcriptional repression 
 Methylation (H4-R3) Transcriptional activation 
Table 1: Consequences of defined histone modifications 
 
Histone acetylation of the ε-amino group of defined lysine residues is the most abundant 
and therefore been the most investigated histone modification. The state of histone 
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acetylation results from the dynamic equilibration of enzymes histone acetyltransferases 
(HATs) and histone deacetylases (HDACs). (Turner, 2000) 
HATs transfer acetyl groups from Acetyl-Coenzyme A to lysine residues in the N-termini of 
the core histones. (Tanner et al., 2000) This leads to a local expansion of the chromatin and 
allows regulatory proteins of gene transcription to access the DNA. Gene transcription is 
mostly activated by histone acetylation. 
HDACs remove acetyl groups from the ε-amino group of lysine residues and so counteract 
the activity of HATs. Because of this contrary mechanism to the HATs, it was assumed that 
HDAC activity results in transcriptional repression. In fact this assumption is correct in most 
of the cases but the transcription of some genes can even be activated by the activity of 
HDACs. There are several mechanisms which could explain this dual function of HDACs: If a 
gene coding for a transcriptional repressor is silenced by histone deacetylation, genes acting 
as substrate for this repressors get activated. Or the altered chromatin density changes the 
activity of transcriptional repressors and therefore increases expression of defined genes. 
Finally some transcription factors like p53, E2F, and GATA are known as substrates for 
HDACs. The deacetylation could result in an activation or repression of the transcription 
factor and so gene expression is altered depending on the gene and transcription factor. 18 
human HDACs have been identified until now and they are divided into three classes 
depending on their homology to yeast Saccharomyces cerevisiae HDACs. Class I HDACs are 
expressed in nearly all human cells and tissues and are located in the nucleus. HDAC1, 
HDAC2, HDAC3, and HDAC8 belong to this class. HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, 
and HDAC10 can shuttle between the nucleus and the cytoplasm and form the class II. The 
HDAC11 could not relate to class I or II because the sequence is not homolog to any of these 
classes. The structure of class III HDACs is highly distinct from class I or II. Because of their 
homology to the yeast protein Sir2 (silent information regulator 2) they are named SIRT1, 
SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, and SIRT7. Their special enzymatic mechanism needs NAD+ 
as a co-factor. (Mottet and Castronovo, 2008) ADP-ribose residue of the NAD+ accepts the 
acetyl group, which is then separated from the histone or protein. (Jackson et al., 2003) 
1.1.4. Small RNAs 
Small RNAs consist of 21 to 30 nucleotides and they play a regulating role in a broad range of 
biological pathways including regulation of gene transcription. For example some prevent 
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the jumping of transposons, are important stem cells and tissues development, regulate cell 
division and control insulin secretion. (Zamore and Haley, 2005) Small RNAs can be divided in 
several classes: microRNAs (miRNAs), small interfering RNAs (siRNAs), repeat-associated 
small interfering RNAs (rasiRNAs), and Piwi-interacting RNAs (piRNAs). (Kloosterman and 
Plasterk, 2006) Together with associated proteins small RNAs establish RNA silencing 
pathways that regulate transcription, chromatin structure, genome integrity, and mRNA 
stability. Associated proteins are double-stranded RNA (dsRNA)-specific endonucleases, 
dsRNA binding proteins, and small RNA binding proteins. (Zamore and Haley, 2005) 
siRNAs can be derived from double-stranded RNA and lead to mRNA degradation. Therefore 
a perfect complementarity is necessary. rasiRNAs are associated with genomic repeats and 
retrotransposons. piRNAs are 29 to 30 nucleotides long and they are germ-line specific. They 
bind to P-element induced wimpy testis (Piwi) proteins which are important for the cell 
division of germ line cells. (Kloosterman and Plasterk, 2006) 
The most prominent and most investigated class of small RNAs by now is that of the miRNAs. 
The product of transcription of micro 
RNA-genes are so called pri-miRNAs 
up to several kilobases long. These 
pri-miRNAs are shaped like an 
imperfect hairpin on which the 
mature miRNA is located on one arm. 
In the nucleus of mammalian cells a 
complex is located where the 
maturation of the miRNA starts. It 
consists of the RNase III enzyme 
Drosha and the double stranded 
RNA-binding protein DGCR8. This 
microprocessor cleavage yields a 65 
to 75 nucleotide pre-mi RNA, which 
is then exported to the cytoplasm. 
The RNase III enzyme Dicer trims the 
pre-miRNA to its mature 21 to 23 Figure 3: miRNA interference (Khanna  D. et al., 2007) 
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nucleotides length. One strand of the miRNA is loaded to the RNase Argonaute2 (Ago2). The 
reference of the loaded strand matches the reference of the target mRNA on the 3´-
untranslated region (3´UTR). Together with other proteins the RNA-induced silencing 
complex (miRISC) is formed. Given perfect complementarity between the miRNA and the 
mRNA, the mRNA is cleaved by Ago2 between bases 10 and 11 measured from the 5´ end of 
the miRNA. If the complementarity is incomplete, miRISC causes translational repression and 
destabilization of the targeted mRNA. (Ku and McManus, 2008) There are evidences that this 
decay of mRNA takes place in a certain dynamic compartment of the cytoplasm called P-
body. The miRNA interference pathway establishes a very complex regulatory system 
because a single miRNA can repress translation of up to over 100 mRNA and a single mRNA 
can be targeted by many miRNA. (Bruno and Wilkinson, 2006) These multiple target sites are 
features of the so-called switch targets that lead to a strong repression. Fine-tuned mRNAs 
possess only one binding site for one miRNA. They have in only a weak regulatory capacity. 
The majority of miRNA regulated processes belong to the fine-tuning type. It has its great 
significance when the target gene expression is low. Gene products of housekeeping genes 
have shorter 3´UTR preventing them be targeted by miRNAs. During development miRNAs 
are expressed in a tissue specific manner. Thus, miRNAs are important for the development 
and maintenance of specific tissues. The importance of miRNAs was demonstrated in the 
mouse model: mice lacking miRNAs were nonviable and died during embryonic phase. 
miRNAs are not only regulators of the developmental timing but they are also involved in 
signaling pathways. Apoptosis and metabolism are under the influence of miRNAs. 
(Kloosterman and Plasterk, 2006) For example a fly miR-14 mutant showed obesity and 
increased triacylglycerol levels. MiRNAs appear to play a role in fat metabolism and energy 
homeostasis. (Teleman et al., 2006) A silencing interference is also involved in mygenisis, 
carcinogenesis, and brain functions. Tumors show altered patterns of miRNAs expression but 
it is still unclear whether this is a cause or a consequence of cancerogenesis. (Kloosterman 
and Plasterk, 2006) 
1.2. Epigenetic phenomena in mammals 
1.2.1. Genomic imprinting 
Genomic imprinting is a gene silencing on one allele by epigenetic mechanisms. Thus only 
one out of two homologous genes is expressed in a parent-of-origin manner. Imprinted 
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genes act functionally haploid and therefore they are not protected from recessive 
mutations like diploid genes usually are. (Dolinoy et al., 2007) Three mechanisms have been 
suggested to cause this effect: DNA methylation, chromatin modification and noncoding 
RNAs. 90 imprinted genes are identified in humans by now and most of them are tissue 
specific or affect developmental timing. They are often found in clusters and are controlled 
by an imprinting control region (ICR). (Ideraabdullah et al., 2008) Paternally expressed genes 
tend to promote growth of the offspring; maternally expressed genes tend to suppress 
growth. In an evolutionary context, genomic imprinting might have evolved to handle 
mother’s resources during pregnancy and breastfeeding, known as the kinship theory. 
(Stoger, 2008) Imprinted syndromes are functional disorders caused by mutations or 
dysregulation of imprinted genes. Three genetic mechanisms are suggested: (i) large 
deletion or duplication of imprinted regions, (ii) DNA mutations in imprinted genes or their 
imprinting control center, (iii) uniparental disomy (two copies of a chromosome from one 
parent and none from the other). So called epimutations lead to epigenetic disorders of 
gene silencing. Hypermethylation or loss of methylation can occur and lead to a defective 
gene expression. (Amor and Halliday, 2008) Prader-Willi syndrome, Angelman syndrome and 
Beckwith Wiedemann syndrome are examples for imprinting disorders. (Dolinoy et al., 2007) 
Many imprinted genes show aberrant gene expression in cancer cells leading to the 
assumption that imprinting disorders could increase the susceptibility to cancer. (Murphy 
and Jirtle, 2003) Loss of imprinting and aberrant expression of H19 (a long noncoding RNA) 
and insulin-like growth factor 2 (IGF2) are associated with somatic overgrowth, embryonic 
tumors and are linked to more than 20 types of cancer. (Ideraabdullah et al., 2008) 
1.2.2. X chromosome inactivation 
In female mammals including humans one of the two X chromosomes is inactivated by 
epigenetic mechanisms. The affected X chromosome is chosen at random early in embryonic 
development and becomes the inactivated X chromosome (Xi). The transcription silencing 
occurs by DNA methylation and histone acetylation. The Xi is hypermethylated on CpG-
islands and gene promoter regions and hypoacetylated on histone H4. (Dolinoy et al., 2007) 
The inactive state is clonally transmitted throughout cell division. A X-chromosomal 
inactivation center (XIC) controls the X-inactivation specific transcript genes Xist and Tsix, 
which help in the silencing process. These genes encode long noncoding RNAs. 
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(Ideraabdullah et al., 2008) Xist RNA represses the Tsix expression by coating the 
chromosome on the inactive chromosome and Tsix RNA avoids Xist expression on the active 
chromosome. Xist is hypermethylated on the active X and unmethylated on Xi. (Dolinoy et 
al., 2007) 
1.2.3. The Agouti mouse model 
The wild type agouti gene encodes a paracrine signaling molecule that produces either black 
eumelanin or yellow phaeomelanin. The transcription of both is initiated from a 
developmentally regulated promoter, which is hair cycle specific. During a certain stage of 
hair growth phaeomelanin is expressed resulting in a sub-apical yellow band on each black 
hair. This phenomenon causes the brown coat color of the wild-type mice. Through the 
insertion of a retrotransposon the metastable epiallele Avy is formed, including a cryptic 
promoter. Metastable epialleles are identical alleles that are variably expressed through 
epigenetic modifications early in development. This additional promoter leads to ectopic 
Agouti transcription and affects all cells. The phenotype of these mice is altered to yellow 
fur, obesity, diabetes, and increased susceptibility to cancer. DNA methylation correlates 
inversely with ectopic Agouti expression. Different degree of methylation causes a wide 
variation in coat color ranging from yellow (unmethylated) to dark brown (pseudoagouti, 
methylated). 
The variable methylation state depends on maternal 
nutrition and environmental exposure during early 
phases of pregnancy. 
For example the epigenetic influence of bisphenol A 
(BPA) was studied using the agouti mouse model. BPA 
is used in the manufacture of polycarbonate plastics 
and epoxy resins and it can be found in many 
commonly used items including food and beverage 
containers, baby bottles, and dental sealants. To 
investigate the effects of BPA to the fetal epigenome, 50 mg BPA/kg was added to the 
mother´s diet 2 weeks prior to mating and throughout gestation and lactation. This exposure 
shifted the coat color of the offspring carrying the Avy epiallele toward yellow and decreased 
the methylation on nine CpGs in the Avy cryptic promoter. The effect of BPA is not gene 
Figure 4: Agouti mice (Dolinoy et al., 
2007) 
INTRODUCTION 20 
 
specific and hypomethylation was also induced on other epigenetically labile genes. 
Supplementation of maternal diet with methyl donors (e.g. folic acid, betaine, vitamin B12, 
choline) or the phytoestrogen genistein prevented the loss of methylation and so protected 
the offspring from obesity, diabetes and cancer. The phenotype resulting from epigenetic 
modifications in early embryonic development persist transgenerationally despite lack of 
continued exposure in subsequent generations. This example demonstrates how simple 
changes in diet or environment can affect the epigenome and the phenotype. (Dolinoy, 
2008) 
1.3. Epigenetic and nutrition 
The agouti mouse model illustrates the influence nutrition has on epigenetic mechanisms 
and how epigenetic mechanisms can affect body composition. Several ongoing research 
projects aim at investigating the mostly unexplored complex associations between nutrition 
and epigenetics. 
As seen in the metastable Agouti-epiallele, DNA methylation plays an important role in the 
interaction between nutrition and epigenetics. (Dolinoy et al., 2007) As mentioned above 
(SAM) is the universal methyl donor for DNMTs and other enzymes involved in methylation 
reaction. It is exclusively provided by folate-mediated one-carbon metabolism and is a 
metabolite of the methionine-homocysteine cycle. (Delage and Dashwood, 2008) High 
abundance of methyl donor enhances the production of SAM. Such methyl donors appear 
naturally in the diet, e.g.: folic acid, vitamin B12, choline and betaine. (Dolinoy et al., 2007) A 
diet rich in these nutrients can increase the methylation of CpGs in an unspecific manner. 
(Dolinoy, 2008) Other nutritional components like catechols, phytochemicals and metals can 
also interfere with the methionine-homocysteine cycle. They alter methyltransferases 
activity, affect the SAM/S-adenosylhomocysteine (SAH) ratio and DNA methylation. A diet 
low in methyl donors and genetic polymorphisms in folate metabolism have been associated 
with aberrant DNMT expression, global DNA hypomethylation, and increased cancer risk. 
A number of natural food compounds can influence the activity or expression of HDACs and 
therefore the acetylation status of histones. Another epigenetically active compound is the 
short chain fatty acid butyrate, which is a fermentation product of the gastrointestinal 
microbiota. Other dietary substances that influence HATs and/or HDACs activity are found in 
garlic (organosulfur compounds e.g. diallyl disulfide) and cruciferous vegetables (e.g. 
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isothiocyanates, sulforphane and 6-methylsulfinylhexyl). HDAC modulating agents are 
objectives of several research projects due to their potential as cancer therapeutic. (Delage 
and Dashwood, 2008) 
As described in the Agouti mice the mother´s diet has a great impact on the epigenome of 
her offspring. (Dolinoy, 2008) The most critical time points for epigenetic reprogramming are 
the fetal period and the early postnatal development. (Junien, 2006) This altered epigenome 
is heritable and transgenerationally maintained. It was reported in some human population 
studies that the nutritional condition of the grandparents could affect the phenotype of the 
grandchildren. Genetic mutations cannot explain the observed effects and so epigenetic 
inheritance was assumed. (Feil, 2006) 
One of the most popular examples to study the effect of maternal nutrition on the unborn is 
the Dutch hunger winter 1944-45. Individuals who were exposed to this famine prenatally 
can be traced because the health care system worked during this clearly defined period and 
the official food rations were documented. The methylation of the IGF2, which plays a 
crucial role in growth and development, was investigated in individuals exposed to the 
famine periconceptionally. However, the birth weights of the participants were within the 
normal range because they were delivered after the end of this hunger period. All CpG sites 
except one were significantly less methylated than unexposed controls. Contrarily no 
differences were found in participants born in or shortly after the famine. Their exposure 
was in late gestation. These findings introduce that epigenetic programming takes place in 
very early phases of development. (Heijmans et al., 2008) 
Data collected in Sweden add evidence that the cardiovascular disease mortality of the 
grandchildren depended on the food availability of their grandparents. The risk for diabetes 
and CVD was low, if the paternal grandfather was exposed to poor nutrition during the years 
before adolescence, the so called slow growth period. Contrarily diabetes mortality 
increased if the availability of food was high. This phenomenon could not be explained by 
genetic variations, so it was assumed that epigenetic mechanisms lead to these differences. 
Alteration in genomic imprinting is unlikely to be the reason, because genomic imprinting 
happens in the very early embryonic development. Thus other epigenetic mechanisms 
involving DNA or histone modulation or miRNA interference, which are inherited down the 
male line, might explain these interesting findings. (Kaati et al., 2002) 
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1.4. The Interleukin 8 gene (IL-8) 
IL-8 belongs to the inflammatory mediators and act as a chemokine. In this function it is 
inducing chemotaxis, which is the directed migration of cells to a site of inflammation. 
Neutrophils, which indicate an acute inflammatory response, follow an IL-8 gradient towards 
higher concentrations and are activated by this chemokine. Monocytes and macrophages 
are the main cellular sources of IL-8 but all nucleated cells of the body can produce it. The 
secretion is induced by multiple stimuli including lipopolysaccharide, living bacteria, and 
other cytokines such as tumor necrosis factor and IL-1. Its production takes place early in the 
inflammatory process but IL-8 persists over a prolonged period of time. The gene expression 
of IL-8 can be regulated by oxidative or anti-oxidative agents respectively. (Remick, 2005) 
Minute quantities of chemokines can cause enormous reactions of immune response. The 
expression of these genes is tightly regulated, primarily at the transcription level. Without 
stimuli the transcription of inflammatory mediators needs to be silenced to prevent 
improper immune reactions. Aberrant expression and activity are the reasons for a variety of 
immune disorders. The basal transcription of IL-8 also depends on the grade of cell 
differentiation. The human colon carcinoma cell line Caco-2 expresses IL-8 in the 
preconfluent state at a high level. After differentiation the IL-8 expression is silenced. (Wen 
and Wu, 2001) 
Some breast cancer cell lines and other cancer cells show enhanced IL-8 expression due to 
aberrant histone acetylation. These observations suggest that differential acetylation of 
histones and transcription factors play an important regulatory role in neoplastic process. 
(Chavey et al., 2008) Transfection studies with reporter genes showed that the elements in 
the IL-8 gene required to silence expression in postconfluent Caco-2 cells are not located 
within the immediate 5´-flanking region of the gene. Furthermore the transfection with 
marked mini-genes lead to the conclusion that the entire immediate IL-8 gene locus lacks 
elements required to silence IL-8 expression. Inhibiting HDACs by trichostatin A (TSA) or 
butyrate could reduce IL-8 expression. But the silencing of the basal activity occurs in a HDAC 
independent manner. (Wen and Wu, 2001) Another study proofed that a mutation on the 
NF-κB binding site in the IL-8 promoter abolished the response to TSA. This result introduces 
that the regulation of the IL-8 transcription by histone deacetylases activity is mediated by 
the NF-κB and tumor necrosis factor α (TNFα) pathway. (Chavey et al., 2008) Downstream 
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NF-κB the activation of the MAP-Kinase pathway is known to modulate IL-8 expression in 
various cell systems. These mechanisms influence the phosphorylation of histone H3, which 
is responsible for accessibility of NF-κB to target promoters. Further acetylation at lysine 9 
and tri-methylation at lysine 4 reflect positive modulation of transcription. (Raymond et al., 
2009) Also variants of histones play a regulatory role in IL-8 expression. MacroH2A is a 
vertebrate specific H2A variant for example enriched on the inactive X chromosome. It is 
structurally different to other histone variants and so it is suggested that incorporation of 
macroH2A into nucleosomes could confer an epigenetic mark for gene expression. 
Agelopoulos et al. reported that the content of macroH2A in the nucleosomes of different 
cell types determines the expression of IL-8 and how much it can be stimulated. MacroH2A 
masks the binding site of NF-κB in the promoter region inhibiting its binding to the DNA. 
(Agelopoulos and Thanos, 2006) 
Not only histone modification but also DNA methylation plays an important role in the 
epigenetic regulation of IL-8 expression. Investigating different breast cancer cell lines it was 
reported that metastatic cancer types express high levels of IL-8 whereas non-metastatic 
cancers do not. These results corresponded to the methylation of two CpG-sites 1.2 kb 
upstream the promoter region. The methylation at these sites correlated positively with the 
mRNA levels. This finding is contrary to the common assumption of gene silencing through 
high methylation states. In addition no regulatory effects of CpG-sites within or near the 
promoter region of the IL-8 gene could be observed. Several mechanisms might explain 
these findings. For example the methylated cytosines inhibit the binding of a repressor 
within the vicinity of the two CpGs. Alternatively, the regulatory sites may serve as a center 
around which a protein complex forms and remodels chromatin structure leading to an up-
regulation of IL-8. (De Larco et al., 2003) 
1.5. Characterization of the used epigenetically active agents 
1.5.1. Butyrate 
Short chain fatty acids such as butyric acid are produced by the 
gastrointestinal microbiota through the breakdown of non-
digestible fibers. Butyric acid serves as the preferred energy source 
for colonocytes and about 95 % is transported across the 
Figure 5: Structure of 
butyric acid 
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epithelium. Concentrations in portal blood are undetectable because of the rapid utilization. 
(Pryde et al., 2002) 
The epigenetic effect of butyrate is mainly caused by the non-competitive inhibition of 
HDACs, especially class I and II, leading to a histone hyperacetylation. Theoretically silenced 
genes should be reactivated by this mechanism, but several studies indicate that a high 
number of genes are down-regulated. An up-regulation of tumor suppressor genes after 
treatment with butyrate has been reported and an increased histone acetylation in the 
promoters of these genes was detected. This mechanism could explain the growth arrest 
and/or apoptosis properties of butyrate and its anti-tumourogenic properties. (Rada-Iglesias 
et al., 2007) But only the expression of 2 % of all mammalian genes is influenced through the 
HDAC inhibitoring activity of butyrate. These findings suggest the existence of a butyrate 
response element in the promoter regions of the affected genes. The transcription factors 
Sp1 and Sp3 are located within the butyrate response element binding sites. These 
transcription factors can act as activators or repressor of transcription. For example the 
promoter region of the gene p21Waf1/Cip1, which plays an important role in the cell cycle, 
contains six Sp1-binding sites. Butyrate induces expression of p21Waf1/Cip1 and prevents the 
cell to enter S phase. The cell is arrested to the G1 phase and undergoes differentiation or 
apoptosis. (Davie, 2003) Other genes involved in cell cycle are also regulated by butyrate. 
(Della Ragione et al., 2001) Treatment of the liver cell carcinoma cell line HepG2 with 
butyrate lead to an increase global histone acetylation as expected but also to a decreased 
histone acetylation at the promoter region of about 1 % of all genes. This loss of acetylation 
was reversible upon withdrawal of the drug and could also be seen with other HDAC 
inhibitors like trichostatin A. CpG islands were significantly more common in deacetylated 
regions. This finding points towards a mechanistic link between DNA methylation and 
histone acetylation. But it is not yet clear if the histone deacetylation is the reason or the 
consequence of gene silencing in these cases. It also seems possible, that these epigenetic 
alterations are responses to stress caused by the butyrate treatment of the cells. (Rada-
Iglesias et al., 2007) Other SCFAs such as acetate or propionate also have epigenetic effects 
but to a less extent. (Pryde et al., 2002) 
In concentration from 5 to 100mM butyrate shows apoptotic activity. This property involves 
the caspase-3 pathway. Butyrate causes cleavage of the pro-enzyme caspase-3 to its active 
form. Also pro-apoptotic proteins like bak increased after butyrate treatment whereas the 
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expression of the anti-apoptotic proteins like bcl-2 was not altered. Cycloheximide, which 
inhibits protein synthesis, could prevent butyrate induced apoptosis. This shows that 
additional intermediate steps requiring protein synthesis must be involved. The caspase-3 
inhibitor zVAD-FMK could also prevent apoptosis. This shows that the pro-apoptotic activity 
of butyrate depends on the caspase-3 pathway. (Ruemmele et al., 1999) 
The anti-inflammatory properties of butyrate result from inhibited activation of the 
transcription factor NF-κB. (Pryde et al., 2002) 
1.5.2. Genistein 
Genistein (4´,5,7-trihydroxyflavone) is an isoflavonoid naturally 
occurring in soy. It is a potential chemopreventive agent against 
various types of cancer. Its anit-cancerogenous effect might be 
attributable to several mechanisms: prevention of DNA 
mutation, reduction of cancer cell proliferation, inhibition of 
angiogenesis, and induction of differentiation. (Li et al., 2009) Genistein has been shown to 
have estrogenic properties, anti-neoplastic activity in several tumors, and is an inhibitor of 
protein tyrosine kinases, which play key roles in cell growth and apoptosis. These 
characteristics may be the results of an epigenetic impact of genistein. The activation of 
nuclear factor kappaB (NF-κB) is inhibited, which could be mediated via the AKT signaling 
pathway. The serine/threonine protein kinase AKT functions downstream of 
phosphatidylinositol 3-kinase (PI3K) in response to mitogen or growth stimulation. Activation 
of AKT prevents apoptosis by multiple mechanisms and is associated with the development 
and metastasis of several kinds of cancer. Additionally genistein modulates the activity of the 
transcription factors NF-κB and the fork head transcription factors (FOXO) influencing 
apoptosis indirectly. FOXO is induced by genistein and acts downstream the phosphatase 
and tensin homolog (PTEN) tumor suppressor, which down-regulates the activity of AKT. NF-
κB is involved in proliferation, apoptosis, inflammation, and immune response. The activities 
of both mentioned transcription factors are regulated by the Sirtuin SIRT1, which belongs to 
the atypical class III HDACs. SIRT1 was identified to play a role in anti-apoptosis, neuronal 
protection, cellular senescence, aging, and longevity. A variety of transcription factors is 
down-regulated by SIRT1 and is not inhibited by TSA like other HDACs. It might promote 
tumorgenesis because an up-regulation of SIRT1 was observed in tumor cells. A study from 
Figure 6: Structure of 
genistein 
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Kikuno et al. aimed at the mechanistic pathway of genistein. The following explorations were 
made: Genistein inactivates the AKT-pathway via inhibition of PI3K and increases the mRNA 
levels of PTEN, the tumor suppressor gene p53, and FOXO3a. The nuclear translocation of 
NF-κB is blocked and so its DNA-binding activity is decreased. Genistein lowers the 
expression of SIRT1 and so increases the histone acetylation of H3K9 in several gene 
promoter regions like PTEN and FOXO3a. The methylation of these sites decreases parallel. 
These effects result in enhanced expression of these genes. (Kikuno et al., 2008) 
The cancer preventive properties of genistein could also be explained via its impact on 
telomerase activity. Telomerases add a repeating DNA sequence (the telomere) to the end 
of chromosomes at each DNA replication, which guarantees stability. The telomere is 
normally shortened during each cell cycle finally resulting in apoptosis once the telomere is 
consumed. In multiple cancer cells the activity of telomerase is increased and apoptosis 
prevented. Genistein was shown to repress telomerase activity in cancer and precancer cell 
lines and may thus prevent the development of tumors. (Li et al., 2009) 
1.5.3. Folic acid 
Folic acid is a water soluble vitamin and is 
essential for numerous body functions because it 
acts as one-carbon donor. It exerts three major 
functions related to DNA metabolism. For the 
conversion from deoxyuridine to thymidylate 
folic acid serves as methyl donor. Deficiency 
leads to a missincorporation of uracil instead of 
thymidine into DNA. DNA then becomes susceptible to DNA strand breaks and therefore for 
tumorigenic transformation of cells becomes more likely. A folate metabolite also serves as 
substrate for the synthesis of the purines adenine and guanine. Thus a deficiency of folic acid 
may inhibit DNA synthesis by the lack of both purines. The third mechanism how folic acid 
acts in DNA metabolism is the most relevant for epigenetic research: 5,10-
methylenetetrahydrofolate is converted into 5-methyltetrahydrofolate by the enzyme 
methylenetetrahydrofolate reductase (MTHFR). 5-methyltetrahydrofolate is the methyl 
donor for the conversion of homocysteine to methionine, which is activated by ATP to form 
SAM. 
Figure 7: Structure of folic acid 
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SAM is known as methyl donor in many 
methylation reactions including DNA and 
histone methylation. Since cancer cells have 
aberrant DNA methylation pattern folate 
intake and blood levels in an individual might 
modify its susceptibility to cancer. Many 
cancer cell lines are characterized by a global 
DNA hypomethylation and localized regions of 
hypermethylation, leading to a shift of gene 
expression.(Miller et al., 2008) In addition some 
known mutations and SNPs can affect SAM availability. For example the MTHFR SNP C677T is 
a well-described and common variant that increases the dietary folate requirement. 
Polymorphisms and dysfunctions of the choline metabolism interfere with the folate 
metabolism and can so alter the availability of SAM. These associations influence the 
methylation state of the DNA. (Zeisel, 2009)  
1.5.4. Zebularine 
Zebularine is a cytidine analog and was originally developed as a 
cytidine deaminase inhibitor. It acts as DNMT inhibitor by 
forming tight covalent complexes between DNMT proteins and 
zebularine-substituted DNA. Studies in breast cancer cell lines 
confirmed this mechanism. It was seen that depletion of DNMT 
proteins took place instead of changes in mRNA levels of the 
DNMTs. The advantages of zebularine compared to other DNMT 
inhibitors are its high stability and its low toxicity in most tested cell lines. Through 
incorporation into DNA, the agent leads to growth inhibition and increased expression of cell 
cycle regulatory genes in cancer cells. (Billam et al., 2009) It reactivates abnormally silenced 
methylated genes, e.g. genes for cancer related antigens. Therefore it is evaluated as a 
possible therapeutic agent in cancer. Zebularine is incorporated into DNA at a linear velocity. 
The incorporation rate was higher in cancer cells than in normal fibroblasts. In preliminary 
experiments the response to the treatment was higher in cancer cells. The enzyme 
uridine/cytidine kinase may determine the amount of zebularine that incorporates into DNA. 
Figure 8: The methionine-homocysteine-cycle 
(Oregon State University) 
Figure 9: Structure of 
zebularine (Tocris Bioscience) 
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Since lower levels of this enzyme are present in normal cells, this could explain the enhanced 
response of cancer cell lines to zebularine treatment. But it cannot be excluded that the 
incorporation of zebularine into RNA is responsible for the observed effects. (Cheng et al., 
2004) In addition to its low toxicity zebularine induced apoptotic mechanism in breast cancer 
cell lines. In some breast cancer cell lines the expression of the estrogen receptor is silenced 
via epigenetic mechanisms. Treatment with zebularine caused a re-expression of this gene. 
(Billam et al., 2009) 
1.5.5. Epigallocatechin-3-gallate (EGCG) 
EGCG is the major polyphenol of green tea accounting for more 
than 50 % of all green tea polyphenols. Several studies show that 
EGCG exhibits the ability to suppress cancer cell growth, induce 
apoptosis, and inhibit tumor angiogenesis. One of the mechanisms 
which are responsible for these effects is the inhibition of DNMT1. 
(Berletch et al., 2008) It was suggested that EGCG acts both in a 
competitive and in a noncompetitive way. SAM methylates EGCG 
on two methylation sites and is so transformed to SAH. Because SAM is also the substrate 
for DNMTs, this is the competitive pathway of the inhibition. (Fang et al., 2007) Like 
zebularine EGCG can reactivate methylation silenced genes through this pathway. But for 
example the gene coding for the telomerase hTERT is down-regulated even though 
hypomethylation takes place. This could be explained by the enhanced binding of the 
methylation-sensitive transcription suppressor E2F-1. (Berletch et al., 2008) EGCG also 
significant reduced acetylation of histone due to its action as HAT inhibitor. But it does not 
bind to the active sites of histones and none competitively inhibits HAT activity. EGCG 
quenches HATs in a specific and global manner not influencing other enzymes for which 
histones serve as substrate. The balance and the interplay between HATs and HDACs are 
altered by this polyphenol. (Choi et al., 2009) Cancer cells treated with EGCG showed 
enhanced apoptosis. This could be caused perhaps through an oxidant pathway or up-
regulation of pro-apoptotic genes. Different response in different cancer cells leads to the 
assumption that EGCG interferes with multiple pathways. (Berletch et al., 2008) Another 
mechanism induced by EGCG is the suppression of the transcription factor NF-κB, which is 
involved in inflammatory processes. The histone acetylation on the NF-κB binding site on the 
Figure 10: Structure of 
EGCG (Alibaba.com) 
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IL-6 gene is shifted by EGCG leading to an altered binding and activity of the transcription 
factor. Because of that EGCG was seen to act as an anti-inflammatory agent in the mouse 
model. (Choi et al., 2009) 
1.5.6. Chrysin 
Chrysin is a flavonoid naturally occurring in many plants, honey, 
and propolis. Chrysin was shown to possess antioxidant, anti-
allergic, anti-inflammatory, anti-cancer, anti-estrogenic, and 
anxiolytic properties. It also can inhibit enzymes like tyrosinase 
and aromatase and prevents estradiol-induced DNA synthesis. In 
a study in rats with ethanol induced liver disorders chrysin 
elevated the activity of enzymes relevant for oxidative balance like superoxide dismutase 
(SOD) and chloramphenicol acetyltransferase (CAT). Lipid peroxidation decreased 
significantly. (Sathiavelu et al., 2009) No epigenetic investigations of chrysin have been 
published by now. But due to the manifold effects shown by chrysin epigenetic pathways 
and gene regulation e.g. for antioxidative genes seem possible. 
Figure 11: Structure of 
chrysin (chemicalbook.com) 
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2. OBJECTIVES 
The aberrant expression of chemokines such as IL-8 can cause an overreaction of the human 
immune system and therefore lead to multiple disorders. (Remick, 2005) For example an 
over-expression of IL-8 also corresponds with the metastatic potential of various cancer 
types especially breast cancer cell lines. (De Larco et al., 2003) A shifted and elevated pattern 
of chemokines plays a critical role in chronic inflammatory bowel diseases including Crohn´s 
disease and colitis ulcerosa. (Monteleone and MacDonald, 2000) A lot of attention is paid to 
these disorders in nutritional sciences because their development, progression and therapy 
depend on nutrition. It is known that diet and special nutrients can alter the appearance and 
concentration of inflammatory mediators and may alter symptoms of disease. For example 
the diet-dependent fatty acid pattern can smooth acute inflammation phases of some 
disorders. (Lucendo and De Rezende, 2009) 
It was shown in many cell cultures or animal studies, that the expression of IL-8 and other 
cytokines is - among others - regulated by epigenetic mechanisms. These include DNA 
methylation, histone modification and micro RNAs. Less is known how miRNAs influence 
cytokines but both DNA methylation and histone modification have been objectives in 
several studies investigating the regulation of inflammatory mediators. Diet and specified 
nutrients can have epigenetic effects and can shift gene expression patterns. (Dolinoy et al., 
2007) 
The aim of this thesis was to investigate the influence of specified nutrients on the 
inflammatory mediator IL-8 and the epigenetic mechanisms behind the effects. The Caco-2 
cell line was chosen as a model for the human gut because of its similar properties to mature 
enterocytes. (Sambuy et al., 2005) The analyses included DNA methylation and histone 
acetylation of the cells after treatment with well defined agents to explore the effects and 
mechanisms behind. Together with other similar studies these findings might have multiple 
impacts: Firstly, they can serve as a start point for further research on individualized diet for 
the prevention of inflammatory processes. Secondly they emphasize the increasing 
importance of epigenetic mechanisms as targets for drug development. 
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3. MATERIALS AND METHODS 
3.1. Polymerase Chain Reaction (PCR) and real-time PCR analysis 
Real-time PCR follows the same principle like end-point PCR: DNA is amplified which makes a 
very little amount of DNA detectable. Unlike an end-point PCR in real-time PCR the 
monitoring of the PCR-product takes place while the reaction is proceeding (real time) and 
not afterwards. Because of the sensitivity of the different detection systems the DNA 
amount can be quantified. 
For a PCR reaction following components are necessary: 
 Deoxynucleotidetriphophats (dNTPs) of the four DNA-bases Adenine, Guanine, Cytosine, 
and Thymine as building blocks for the new synthesized DNA fragments. 
 DNA-Polymerase is the enzyme which builds DNA out of dNTPs. 
 Magnesium chloride as a co-factor of the DNA-Polymerase. 
 Primers are short oligonucleotides of about 15 to 40 base pairs length which function as 
start signal for the DNA-Polymerase. 
 Fluorescent reporter to detect and quantify the synthesized DNA. (only in real time PCR) 
3.1.1. Primer 
Primers act as start signals for the DNA-polymerase in the PCR. Primers are essential not only 
for the PCR reaction but also for DNA-replication because DNA-polymerase is not able to 
initiate the replication but only to elongate already existing DNA-fragments. It is necessary 
to apply a pair of primers, a forward and a reverse one to amplify double stranded DNA. The 
short oligonucleotides bind to the DNA sequence complementary to their own sequence. 
Through the choice of the sequence specific gene – or promoter regions of interest can be 
amplified.  
3.1.2. The PCR reaction 
A PCR consists of 30 to 40 cycles of denaturation, annealing and elongation. 
 Denaturation: In this first step the DNA is denatured at a temperature of 90°C to 95°C. 
 Annealing: In this step the primers bind to their target DNA sequence. The temperature 
depends on primer sequence, usually between 50°C to 70°C.  
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 Elongation: At a temperature of 72°C the polymerase builds a DNA strand starting at the 
annealed primer. 
 
 
Figure 12: Principle of a PCR reaction (Torak et al.) 
 
The amount of DNA copies is doubled during each cycle and can be formulated 
mathematically as follows: 
N = N0 x 2
n 
N: number of DNA copies 
N0: initial number of DNA-molecules 
n: number of cycles 
2: optimal efficiency, which means that after every cycle 2 DNA molecules resulted out of 
one. This optimal efficiency is hardly ever reached. 
3.1.3. Real time PCR detection systems 
Hydrolysis probe technique 
In addition to the two primers a third oligonucleotide, the probe, is used. At the 3´and 5´ 
ends of the probe a fluorescent dye (fluorochrome) and a quencher are attached. The 
quencher absorbs the fluorescence of the reporter as long as the probe is intact. The probe 
anneals to the single stranded DNA between the two primers and gets destroyed during the 
DNA elongation due to the exonuclease activity of polymerases. So the fluorochrome and 
the quencher get separated and the fluorescence can be detected. During each cycle of the 
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PCR reaction more probe is hydrolyzed and the signal increases exponentially. Techniques 
that rely on this principle are TaqMan, Beacons, and Scorpions. (van der Velden et al., 2003) 
Hybridization probe technique 
For this system two oligonucleotides binding direct next to each other on the 
DNA are necessary. One probe is labeled with a donor fluorochrome and the 
other one with an acceptor fluorochrome. If both probes anneal to the DNA, 
the emitted light of the donor will excite the acceptor whose emitted 
fluorescence can be detected during the annealing phase. The signal is 
increasing after each cycle because more DNA copies are available to bind for 
the probes. (van der Velden et al., 2003) 
 
DNA-binding agents 
A fluorescent agent binds to double stranded DNA after the elongation phase 
and so the signal increases with an increasing amount of DNA. One of the 
most popular dyes for this technique is Sybr Green, which is also used in these 
experiments. (see Figure 13) (van der Velden et al., 2003) 
 
 
Figure 14: Example for result curves of a real-time PCR reaction 
 
 
 
Figure 13: 
Principle of 
Sybr Green 
(van der 
Velden et al., 
2003) 
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3.2. Cell culture conditions and treatment 
For this experiment the human colon carcinoma cell line Caco-2 was used. The cells were 
grown in RPMI 1640 media, which was supplemented with 10 % heat-inactivated fetal 
bovine serum, 4 mM glutamine, and 100 units each of streptomycin and penicillin. After 
about 14 days of growth, cells were treated as listed in table 2 for 48 hours. 
 
substances concentration 
butyrate 5 mmol/l 
genistein 200 µmol/l 
folic acid 200 µmol/l 
zebularine 100 µmol/l 
EGCG 100 µmol/l 
chrysin 50 µmol/l 
Table 2: Added agents and concentrations 
 
The cell media was stored in aliquots to use for ELISA. The cells were washed twice with ice-
cold PBS before proceed to DNA methylation analysis and ChIP. 
3.3. Enzyme-linked immunosorbent assay (ELISA) 
To get a fast overview whether the treatment of the cells altered the IL-8 gene expression an 
ELISA assay for the IL-8 protein in the cell supernatant was performed. 
3.3.1. Principle of the method 
A 96 well microtiter plate is coated with an antibody against IL-8, which binds to the ground 
and walls of the wells (capture antibody). An IL-8 standard curve and the samples are applied 
to the plate. During incubation the IL-8 proteins bind to the immobilized antibody. For 
detection another antibody (detection antibody) is added to each well which is conjugated 
to an enzyme. Through adding a substrate for the enzyme color development takes place 
depending on the antigen concentration. An UV plate reader detects the different intensities 
of the color. Standard dilutions allow quantification of IL-8 in the samples. (Porstmann and 
Kiessig, 1992) 
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3.3.2. Procedure 
For this experiment the IL-8 Eli-pair kit from Diaclone was used. 
Coating 
 Per plate 50 µl of the capture antibody was diluted in 10 ml of coating buffer. 
 100 µl of the solution were pipette into each well of the plate. 
 The plate was sealed and incubated overnight at 4°C. 
 On the next day the wells were emptied and washed twice with 400 µl of wash buffer. 
 250 µl of saturation buffer were applied to the wells and incubated for 2.5 hours at room 
temperature. 
 After that the saturation buffer was discarded and the plate dried one day at room 
temperature. 
Sample application 
 A standard curve was diluted following the scheme below using the standard stock 
solution and the standard diluent buffer: 
 
standard concentration [pg/ml] volume standard volume buffer 
1 – stock solution 2000   
2 1000 210 µl standard 1 210 µl 
3 500 210 µl standard 2 210 µl 
4 250 210 µl standard 3 210 µl 
5 125 210 µl standard 4 210 µl 
6 62,5 210 µl standard 5 210 µl 
Table 3: Concentrations of the standards 
 
 100 µl of each standard and each sample were applied to the wells in duplicate. Two 
wells contained only standard diluent buffer as blanks. 
 The plate was incubated for two hours at room temperature. 
 Following the incubation the wells were emptied and washed three times with 400 µl of 
wash buffer. 
 The detection antibody solution was made out of 100 µl biotinylated detection anti-IL-8 
and 5 ml of biotinylated antibody diluent buffer. 
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 50 µl of the prepared solution were distributed to each well and incubated for one hour 
at room temperature. 
 The plate was emptied and washed three times with 400 µl of wash buffer. 
Color development 
 5 µl of horseradish peroxidase-streptavidin (HRP-streptavidin) were diluted in 500 µl of 
HRP-streptavidin diluents buffer and 150 µl of this solution was again diluted in 10 ml of 
the same buffer. 
 100 µl of the HRP-streptavidin were dispensed to each well and incubated 20 minutes at 
room temperature. 
 For color development 100 µl of 3,3´,5,5´-Teramethylbenzidine was applied to each well 
and the color was allowed to develop for eight minutes. 
 The color reaction was stopped by adding 100 µl of 1 molar sulfuric acid to the wells. 
 The absorbance was measured immediately at 450 nm. 
Analysis 
The standard curve was drawn in Microsoft Office Excel 2007 and the concentrations of the 
samples were calculated with the determined formula. 
3.4. Gene expression 
3.4.1. Principle of the method 
Messenger RNA (mRNA) is a product of DNA transcription. The amount of mRNA is directly 
proportional to the gene activity. To quantify mRNA it is extracted and converted into more 
stable complementary DNA (cDNA) through reverse transcription. For reverse transcription 
three types of primers can be used: 
 Random hexamer primers: These are small primers of six base pairs length, which bind 
randomly to the all mRNAs existing in the sample. 
 Anchored-oligo(dT) primer: These primers consist only of Thymine and bind to the poly-
A-tail of mRNAs. 
 Sequence specific primers: With this kind of primers only specific genes or part of genes 
are converted during transcription reaction. 
The resulting cDNA is than quantified by real-time PCR. 
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3.4.2. Procedure 
mRNA extraction 
For the mRNA extraction the NucleoSpin RNA II from Macherey-Nagel was used and 
followed the instruction applied. 
Reverse transcription 
To convert the mRNA into cDNA the Transcriptor First Strand cDNA Synthesis Kit (Roche 
Diagnostics) was used. 
 For each sample agents were mixed as following: 
 
Transcriptor reverse transcriptase reaction buffer 4 µl 
Deoxynucleotide mix 2 µl 
Protector RNase inhibitor 0.5 µl 
Anchored-oligo(dT)18 primer 1 µl 
Transcriptor reverse transcriptase 0.5 µl 
water 6 µl 
RNA 6 µl 
total volume 20 µl 
Table 4: Reaction mix for reverse transcription 
 
 The mixes were set at 50°C for 60 minutes for transcription 
 The samples were heated up to 85°C for 5 minutes to inactivate the transcriptase. 
real-time PCR 
The primers, sample composition, and cycling conditions for the gene expression detection 
are listed in the tables below. 
 
Primer Sequence Annealing temp concentration 
IL-8 sense ATG ACT TCC AAG CTG GCC GTG GCT 66°C 5 pmol/µl 
IL-8 antisense TCT CAG CCC TCT TCA AAA ACT TCT C 66°C 5 pmol/µl 
Table 5: Primer sequences, annealing temperatures and primer concentrations for gene expression 
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Sample composition: 
SensiMix 5 µl 
water 2.8 µl 
primer 1 µl 
Sybr Green 0.2 µl 
DNA 1 µl 
total volume 10 µl 
Table 6: PCR reaction mix for gene expression 
 
Cycling conditions: 
Polymerase activation 10 min 95°C 
Cycling 35 times  
Denaturation 45 sec 95°C 
Annealing 60 sec 66°C 
Elongation 60 sec 72°C 
Melt curve 0.5°C every 5 sec 50°C to 95°C 
Table 7: Cycling conditions for gene expression PCR 
 
3.5. DNA methylation detection 
3.5.1. Principle of the method 
For the detection of the methylation pattern on specific DNA-sites the whole genomic DNA is 
extracted from the cells. 
Bisulfite conversion 
The genomic DNA is treated with a reagent containing bisulfite (HSO3
-). During the reaction 
all cytosines which are not methylated are converted into uracil. The methylated cytosines 
stay unchanged because the methylation group acts as a protector. (Hayatsu, 2008) 
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Figure 15: Bisulfite conversion of cytosine (Hayatsu, 2008) 
PCR 
After bisulfite conversion specific genes or part of genes are amplified in a PCR reaction. For 
converted DNA special primers are necessary because the sequence was changed during 
conversion. Nested PCRs are often used in the methylation detection. This means that two 
consequent PCR reactions with different primer pairs are performed. The first pair of primers 
amplifies a piece of DNA which is a little longer than the part of interest. The primers for the 
second PCR amplify the sequence of interest. This approach increases the specificity of the 
reaction. 
Bisulfite Sequencing PCR (BSP) 
After bisulfite conversion a PCR reaction is performed to amplify the interesting part of the 
genome DNA. The PCR-product is purified and sequenced. If there is still a C in the 
interesting CpG-site this means that the C was methylated. If a T is found instead it means 
that the CpG was not methylated. 
Methylation specific PCR (MSP) 
For this method two pairs of primers are necessary. The primers bind exactly to the CpG of 
interest. One pair of primers matches to the bisulfite converted DNA that has been formerly 
methylated and the other one to the formerly unmethylated DNA. It is possible to read out 
the how much of the DNA had been methylated. 
3.5.2. DNA-Extraction 
The DNA was extracted from cells applying the QIAamp DNA Mini Kit from Qiagen following 
the protocol of the manufacturer (see chapter protocols). 
3.5.3. Bisulfite Conversion 
The bisulfite conversion was done with the EpiTect Bisulfite Kit from Qiagen following the 
protocol of the manufacturer (see chapter protocols). 
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3.5.4. BSP 
A nested BSP was performed to determine the methylation status of the CpG-sites -1342 and 
-1412 base pairs upstream the promoter region of the IL-8 gene. The primer sequences and 
PCR conditions are shown in the table 8. The PCR mastermix was purchased from Promega. 
The sample composition (table 9) was the same for both PCRs but for the internal reaction 
the product of the external PCR was diluted 1:100. Cycling conditions are shown in table 10. 
 
Primer Sequence Annealing temp concentration 
external PCR 
sense GGT TGG AGA AAG ATA ATA AAA AGA A 59°C 59 pmol/µl 
antisense AAC ACC AAA TCT AAC CTC TAA AAA C 59°C 59 pmol/µl 
internal PCR 
sense AGT GTG TTT ATA GTG TGG GTA AAT T 58°C 58 pmol/µl 
antisense AAA AAT TTC AAC AAA TCA TAA AAA A 58°C 58 pmol/µl 
Table 8: Primer sequences, annealing temperatures and primer concentrations for methylation PCRs 
 
Sample composition for internal and external PCR: 
 external PCR internal PCR 
Mastermix 5 µl 25 µl 
water 3 µl 15 µl 
primer 1 µl 5 µl 
DNA 1 µl 5 µl 
total volume 10 µl 50 µl 
Table 9: PCR reaction mix for methylation PCRs 
 
Cycling conditions: 
Polymerase activation 10 min 95°C 
Cycling 35 times internal PCR external PCR 
Denaturation 30 sec 95°C 
Annealing 50 sec 59°C 58°C 
Elongation 60 sec 72°C 
Table 10: Cycling conditions for methylation PCRs 
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After the amplification the product of the second PCR reaction was cleaned up with the 
QIAquick PCR purification kit from Qiagen and controlled by gel-electrophoresis. The purified 
product was sequenced by DNA Confidence, Vienna.  
3.6. Chromatin immunoprecipitation (ChIP) 
3.6.1. Principle of the method 
The ChIP procedure is suitable to investigate the interaction between DNA and proteins like 
transcription factors and histones. Because of the treatment of the whole living cells without 
extracting the DNA or chromatin it is possible to explore the structure and the dynamic 
changes in the DNA-protein interactions in their native chromatin environment. ChIP shows 
at which locus of the DNA a protein of interest binds and also modifications are detectable. 
The DNA-protein bonds and protein modifications or interactions affect the structure of the 
chromatin. This changes the transcription of specific genes. 
The DNA-proteins bonds are fixed in the living cells with crosslinking agents such as 
formaldehyde or UV. The use of formaldehyde as crosslinking agent dates back to the 1960s, 
when it was firstly used to consolidate protein/protein, protein/DNA, and protein/RNA 
interactions. The treatment with formaldehyde fixes bonds between the exocyclic amino and 
endocyclic imino groups of the DNA bases and side chain nitrogens of lysine, arginine, and 
histitidine as well as α-amino groups of all amino acids of the protein. These complexes are 
then enriched by precipitation with antibodies 
which are specific to the protein, a component or a 
modification of the protein. After the enrichment 
of the DNA-protein complex the crosslinking can be 
reversed and the DNA as well as the protein of 
interest can be investigated or quantified. ChIP has 
been applied to map the bonds of modified 
histones along target genes, the cell-cycle 
regulated assembly of origin-dependent replication 
and centromer specific complexes, and the in vivo 
position of transcription factors. (Kuo and Allis, 
1999) 
Figure 16: Principle of the ChIP procedure (Kuo 
and Allis, 1999) 
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Caco-2 cells were treated with a crosslinking mix containing formaldehyde. The 
immunoprecipitation took place with an antibody specific for histone H3 which is acetylated 
at the lysine residue in position 9 (H3K9). 
3.6.2. Procedure 
Crosslinking 
 1.5 ml crosslinking mix were added to each flask containing the cells. 
 The flasks were rotated for 10 minutes. 
 1.5 ml of glycine solution (c=1.25 mol/l) were added to each flask to quench the 
crosslinking reaction. 
 1 ml of lysis buffer was spread over the cells and the flasks were incubated for 5 minutes 
at 4°C. 
 The cells were scrapped from the grounds of the flasks and transferred into a 15 ml 
falcon tube. 
Sonication 
To find out how many pulses of sonication are necessary for the appropriate fragment 
length the untreated cell control was used. 
 One impulse of 20 seconds and 50 % power was applied to the lysate. 
 An aliquot of 20 µl lysate was diluted with 80 µl of water. 
 5 µl Proteinase K was added to a final concentration of 500 µg/ml. 
 The aliquot was incubated for 30 minutes at 37°C and over night at 65°C to reverse the 
crosslinking. 
 The DNA was purified with the QIAquick PCR purification kit from Qiagen following the 
instructions provided (see chapter protocol). 
 To control the length of the DNA a gel electrophoresis was run on a 2 % agarose gel with 
4 µl sample at 100 V. 
 The gel was colored in an ethidium bromide solution with a concentration of 0.5 µg/ml. 
The points above were repeated until the DNA of the untreated cells had a length between 
200 and 600 base pairs. When this was achieved all samples were treated as following: 
 8 impulses of 20 seconds and 70 % power to each lysate. 
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 An aliquot of 20 µl of each sample was taken and 80 µl of water and 5 µl of proteinase K 
were added. 
 The aliquots were incubated for 30 minutes at 37°C and over night for 65°C. 
 On the next day the DNA was purified with the QIAquick PCR purification kit from 
Qiagen. 
 A gel electrophoresis on a 2 % agarose gel under conditions mentioned above showed 
the length of the DNA. 
Immunoprecipitation 
As negative controls one additional aliquot of each sample was treated as described 
following but without adding the antibody. 
 Two times 100 µl of each sample were diluted with 900 µl dilution buffer and 100 µl lysis 
buffer. 
 8 µl of the specific antibody was applied to each sample which is up to 4 µg of the 
antibody. 
 The tubes are fixed on an overhead rotator and stored over night at 4°C 
Simultaneously the protein beads were prepared for the further procedure: 
 For each sample 0.2 g of protein A beads are diluted in 1 ml of a mixture of dilution 
buffer and lysis buffer in a proportion of 9:1. 
 120 µl of bovine serum albumin (BSA) which is up to a final concentration of 500 µg/ml 
and 60 µg of sheared salmon sperm DNA were added. 
 The beads rotated over night at 4°C. 
 On the next day the beads were centrifugated at 2000 rpm for 1 minute and supernatant 
was discarded. 
 A wash solution was prepared from dilution buffer and lysis buffer in a proportion 9:1. 
 The beads were washed twice with approximately 2 ml of wash solution and 
centrifugated carefully at 2000 rpm for 1 minute between the washes. 
 Finally the beads were resuspended in 1 ml of the buffer mixture. 
 100 µl of the resuspended beads were added to each tube (samples and negative 
controls) 
 The tubes rotated for two hours at 4°C. 
 After centrifugation at 2000 rpm for one minute the supernatant was discarded. 
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 The protein beads with the absorbed immune complexes were washed four times with 
1 ml of wash buffer. The tubes were rotated for 10 minutes at 4°C containing the wash 
buffer and then centrifugated at 2000 rpm for 1 minute between the washes. 
 A fifth wash was performed using 1 ml of final wash buffer. 
 After centrifugation under conditions used before the supernatant was removed 
carefully and discarded. 
 150 µl of elution buffer, 15 µl of proteinase K, and 15 µl of RNase A leading to a final 
concentration of proteinase K and RNase of 500 µg/ml were added to all tubes 
containing samples, negative controls, and inputs. 
 All tubes were warmed to 37°C for 30 minutes and afterwards incubated at 65°C over 
night to reverse the crosslinking. 
 On the next day the DNA was purified with the QIAquick PCR purification kit from Qiagen 
and eluted with 100 µl of elution buffer. 
To analyze the DNA after the ChIP procedure a Sybr Green real-time PCR system was used. 
Primers and annealing temperature used are listed in table 14 
 
Primer Sequence Annealing temp concentration 
IL-8 sense GAA GTG TGA TGA CTC AGG 62°C 5 pmol/µl 
IL-8 antisense GAA GCT TGT GTG TGC TCAG C 62°C 5 pmol/µl 
Table 11: Primer concentrations, annealing temperature and primer concentrations for ChIP PCR 
 
Sample composition: 
SensiMix 5 µl 
water 2.8 µl 
primer 1 µl 
Sybr Green 0.2 µl 
DNA 1 µl 
total volume 10 µl 
Table 12: PCR reaction mix for ChIP PCR 
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Cycling conditions: 
Polymerase activation 10 min 95°C 
Cycling 35 times  
Denaturation 45 sec 95°C 
Annealing 60 sec 62/67°C 
Elongation 60 sec 72°C 
Melt curve 0.5°C every 5 sec 50°C to 95°C 
Table 13: Cycling conditions for ChIP PCR 
 
 
Figure 17: Real-time PCR curves of the ChIP reaction 
 
3.7. Data and Statistical analysis 
The results of the real-time PCR were analyzed with the software Rotor-Gene Version 6.1 
belonging to the Corbett Rotor Gene 300 real time cycler. Hypothetic concentrations were 
calculated by the software and the amplification efficiency was adjusted between individual 
samples. Average and the standard deviations were calculated with Microsoft Office Excel 
2007. A two tails t-test was used to determine the significance of the results, which also was 
performed in Microsoft Office Excel 2007. Results were regarded as significantly different at 
p<0.05. 
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4. RESULTS 
4.1. IL-8 ELISA 
 
 
Figure 18: IL-8 ELISA 
 
Compared to the untreated cells the treatment with Zebularine and Chrysin for lead to a 
significant 2.1 and 4.5 fold increase in IL-8 production (p<0.01). Genistein decreased the IL-8 
concentration of the cell supernatant to halve compared to the untreated cells (p=0.01). 
Butyrate (0.9), folic acid (1.2), and EGCG (1.1) did not alter the IL-8 concentration 
significantly. 
4.2. IL-8 gene expression 
 
 
Figure 19: mRNA gene expression of IL-8 
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In contrast to ELISA results gene expression analysis on the mRNA level showed a 7.4 fold 
enhanced IL-8 expression after cell treatment with genistein. Zebularine (1.6) and Chrysin 
(1.9) lead to a slight increase of IL-8, but no changes could be observed for butyrate (1.1), 
folic acid (1.2), and EGCG (1.3). 
4.3. DNA-Methylation on CpGs -1342 and -1412 
 
 
Figure 20: DNA methylation on CpG -1342 
 
 
Figure 21: DNA methylation on CpG -1412 
 
A clear 2.8 fold/3.4 fold hypermethylation was observed after treatment with folic acid on 
CpG-sites -1342/-1412 compared to the untreated cells. Butyrate led to a decrease of the 
methylation grade on the site -1342 to 0.3 and on -1412 to 0.6. Genistein (-1342: 1.1; -1412: 
1.2) and zebularine (-1342: 0.9; -1412: 0.9) showed only slight changes in the methylation 
pattern of both CpG-sites. 
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4.4. ChIP 
 
 
Figure 22: ChIP of H3K9 
 
ChIP was performed with cells after treatment with the HDAC inhibitor butyrate. The 
acetylation of H3K9 was 5.2 fold increased, this was significant (p<0.01). 
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5. DISCUSSION 
5.1. Butyrate 
Butyrate is known as HDAC inhibitor. Thus no changes in the grade of DNA methylation could 
be expected. However, a significant decrease of the methylation state of the two CpG-sites 
on the IL-8 gene was observed. One possible explanation for that might be the apoptotic 
effect of butyrate involving the caspase-3 pathway. Activated caspase-3 cleaves several 
substrates including the DNA repair enzyme pol-(ADP-ribose)polymerase (PARP) leading to 
DNA breakdown. The decrease in methylation might be due to a beginning degradation of 
the DNA. (Ruemmele et al., 1999) 
Only few studies were made to investigate the influence of butyrate on the methylation 
pattern of genes. In one of these a hypermethylation of the retinoblastoma gene in the 
human colon tumor cell line HT29 was observed. This confirms our findings, which also show 
an effect of butyrate on DNA methylation. (Gope and Gope, 1993) The present findings 
suggest a hypomethylation of the IL-8 gene through butyrate treatment. Further 
investigation will be necessary to prove these results. 
The histone acetylation on H3K9 significantly increased after treatment with butyrate. This 
result was expected because butyrate is known as HDAC inhibitor. Acetylation of the chosen 
site was shown to correlate with the nucleosome structure. Changes in acetylation have 
previously been linked to a change in gene expression. (Michishita et al., 2008; Strasak et al., 
2009) The lysine residue 9 is located at the end of the histone. That is why modifying 
enzymes can easily access this site. The impact of agents on histone acetylation can thus be 
observed on lysine 9 more clearly than on others. Even though only about 2 % of all human 
genes are responsive to butyrate treatment (Davie, 2003) IL-8 is known to be regulated by 
this SCFA. (Chavey et al., 2008; Davie, 2003; Della Ragione et al., 2001). Butyrate acts as a 
non-competitive HDAC inhibitor particularly affecting class I and II HDACs. (Rada-Iglesias et 
al., 2007) 
The IL-8 expression did not show significant changes after butyrate treatment on mRNA or 
protein level in spite of increased histone acetylation. It has been reported that an increased 
mRNA level after butyrate treatment is not only caused by altered histone acetylation state 
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but also by post transcriptional events (Hirsch and Bonham, 2004). It is a transient event. 
However, Peart et al. observed that HDAC inhibitor treatment results in an early response of 
gene activation, but gene repression increased over time. After 16 hours of HDAC inhibitor 
treatment more genes were repressed than activated. (Peart et al., 2005) Considering these 
results, it might be possible that peak activation had already been over and thus remained 
undetected after 48 hours.  
Butyrate enhances the rate of apoptosis in a dose and time depending manner. Apoptotic 
effects might have rendered impossible to identify changes in gene expression. At a 
concentration of 5mM, which was used in this experiment, the activity of apoptotic enzyme 
caspase 3 was significantly increased. (Ruemmele et al., 1999) Even though butyrate should 
show decreased IL-8 expression due to its anti-inflammatory properties the opposite was 
reported when the Caco-2 cells were immune activated before the treatment. (Wen and Wu, 
2001) So although other results have been expected, the recent findings can be explained by 
the reasons mentioned above. 
5.2. Genistein 
Treatment with 200 µmol/l genistein did not result in significant changes in methylation 
pattern of the two investigated CpGs. Li et al. explored the influence of genistein on breast 
cancer cell lines and linked it to telomerase activity. They found a decreased expression of 
DNMTs leading to a hypomethylation of several genes associated with telomerase activity 
and cancer. But this altered methylation pattern could not be seen in all genes determined. 
(Li et al., 2009) 
Another hint of the methylating potential of genistein was shown in the agouti mouse 
model. Supplementation of genistein to the mother´s diet shifted the coat color of the 
offspring towards pseudoagouti. The methylation grade of the investigated CpGs increased. 
(Dolinoy, 2008) 
Genistein is an anti-inflammatory agent. Decreased IL-8 level as shown by ELISA confirmed 
several previous studies that found a decreased expression. But the mRNA level of IL-8 
increased significantly after genistein treatment for 48 hours. Genistein was seen to slow 
down cell growth in cancer cell lines and hinder DNA synthesis. The increased IL-8 expression 
could thus be a symptom of altered cell cycle and beginning apoptosis. (Handayani et al., 
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2006) Another possible explanation might be a generalized inflammatory response of the 
Caco-cells due to the addition of genistein to their media in excess concentrations. 
Genistein regulates gene expression in a very complex way and so the manner how 
transcription is influenced is hard to predict. Despite the effect on the expression of the 
HDAC SIRT1, which is lowered by genistein (Kikuno et al., 2008) and the decreased 
expression of DNMTs (Li et al., 2009) the estrogenic impact of genistein can also alter the 
gene expression. It binds to estrogen receptor alpha (ERα), which acts as a transcription 
factor upon activation. The activated ERα increases the activity of HATs introducing another 
epigenetic mechanism. (Hong et al., 2004) So even though genistein was objective in many 
studies until now, further investigations will be necessary to understand the holistic 
mechanism by which genistein influences human gene expression. 
5.3. Folic acid 
Folic acid increased the methylation grade of the investigated CpG-sites as expected because 
of its function as methyl group donor. Jang et al. observed cell cultures under condition of 
folate depletion and analyzed their methylation state. They determined a global DNA 
hypomethylation as expected but surprisingly some regions were hypermethylated. For 
example a 5´-CpG island of the H-cadherin gene showed hypermethylation and down 
regulation of gene expression. Presumably, this is a compensatory response. (Jang et al., 
2005) Due to observations in rat liver tissue it was suggested that a hypo- or 
hypermethylation introduced by folic acid acts in a site and gene specific manner. Not all 
responses might be in the same direction. These results were confirmed in cell culture 
studies including Caco-2 cells. Studies in rats showed that DNA hypomethylation did not 
occur in colon-cells by folate deficient diet suggesting that the colorectum may be resistant 
to the hypomethylating effect. It was also suggested that a folate deficiency of a moderate 
degree or short duration induces DNA hypermethylation (as it was seen in rodent liver 
tissue) due to compensatory up regulation of DNMTs. In humans a low folate intake 
decreased the global DNA methylation grade of leukocytes. Colon DNA methylation was 
positively correlated with serum and red blood cell folate concentration and negatively 
correlated with plasma homocysteine. (Kim, 2004b) 
Although in general an increased methylation leads to a decreased gene expression no 
significant alteration in the IL-8 expression was seen on protein or mRNA level. This might be 
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due to too short incubation time. Studies in rodents fed a diet deficient in different 
combinations of methyl group donors induced genomic and protoonocogene DNA 
hypomethylation and elevated levels of corresponding mRNAs. (Kim, 2004b) Methylation on 
specific CpG sites regulates gene expression in differentiated way independent from the 
global DNA methylation grade. Cell culture studies showed that folate depletion can lead to 
an up regulation as well as a down regulation of different genes. The expression of genes 
involved in one carbon metabolism is enhanced to compensate the lack of folic acid. (Jang et 
al., 2005) The expression of DNMTs is also up regulated. (Kim, 2004b) In animal studies this 
response to the folate state of an individual depends on age. Depletion or supplementation 
of folic acid showed an influence of cancerogenisis relevant genes like p53 and ILGF2 
associated with age of the laboratory animals. (Jang et al., 2005) 
Folic acid increases the availability of SAM which is also methyl donor for histone 
methylation enzymes. So it seems possible that not only DNA methylation affects gene 
expression after folate treatment but also epigenetic pathways caused by altered histone 
methylation. Due to the concentration and duration of folic acid treatment in this 
experiment this histone effect might abolish the effect of DNA methylation on gene 
expression. 
5.4. Zebularine 
Although zebularine is a known DNMT inhibitor, no significant changes of the methylation 
state on the investigated CpGs could be seen. This might be due to an improper duration of 
treatment because in several studies alterations of DNA methylation could only be observed 
after more than two days. (Billam et al., 2009; Marquez et al., 2005) The following 
mechanism must also be considered: DNMTs are posttranscriptionally trapped by zebularine 
with DNMT1 as special target. DNMT3a and DNMT3b are just partially reduced. Since DNA is 
not actively demethylated by zebularine, treated cells may still retain substantial 
methylation patterns. (Billam et al., 2009) 
Even though an increase of IL-8 protein could be observed in the ELISA test, no significant 
change was found on the mRNA level. This result is not surprising because no change in DNA 
methylation has been determined. The effect of zebularine an expression of the tumor 
suppressor gene p16 was found to depend on the investigated cell line. So perhaps even 
though the Caco-2 cell line is a cancer cell line, its response to zebularine treatment is 
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weaker compared to other cancer cells. (Cheng et al., 2004) Zebularine does not only alter 
gene expression via its influence on DNA methylation. It is assumed that zebularine 
reactivates silenced genes through an enrichment of histone acetylation on promoter 
regions. (Billam et al., 2009) 
5.5. Epigallocatechin-3-gallate (EGCG) 
EGCG can affect gene expression through several epigenetic mechanisms mentioned in 
introduction. But no significant changes were seen either in the ELISA test or on mRNA level. 
The reasons could be manifold. The incubation time might be too short to see any effects. In 
a study of Fang et al. the mRNA levels after treatment with EGCG started to rise after 72 to 
144 hours depending on the gene although an altered methylation pattern could already be 
seen after 48 hours. (Fang et al., 2007) One pathway by which EGCG acts is the 
demethylation of E2F-1 binding sites and enhanced binding of this transcription repressor. 
(Berletch et al., 2008) This regulatory pathway might not be involved in the IL-8 gene at all. 
This might explain unchanged IL-8 gene expression. Due to the inhibition of NF-κB by EGCG 
gene relevant in inflammatory, e.g. IL-6, processes showed reduced expression after 
treatment. (Choi et al., 2009) No such effect was seen in this study but the effects of EGCG 
were described as cell line and gene specific. (Fang et al., 2007) 
5.6. Chrysin 
Epigenetic gene regulation by chrysin seems possible due to its manifold effects. It was 
described as an antioxidant, anti-allergic, anti-inflammatory, anti-cancer, anti-estrogenic, 
and anxiolytic agent. (Sathiavelu et al., 2009) Chrysin treatment of Caco-2 cells in 50 µmol/l 
caused a significant increase of IL-8 protein abundance but only a slight increase in mRNA. 
These results are contradictory to the postulated anti-inflammatory properties of chrysin. 
Anyhow, anti-inflammatory effects cannot be explained by a single regulator. The reaction of 
Caco cells to treatment with chrysin might also be due to a slightly toxic effect of the 
treatment. Since no epigenetic investigations with chrysin were published till now further 
research might be necessary to determine physiological treatment conditions.
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6. SUMMARY 
Epigenetic is defined as changes in gene expression without changes in the DNA sequence 
and can lead to a shift in phenotypes. There are three epigenetic mechanisms: DNA 
methylation, histone modifications, and interference of small noncoding RNAs. Gene 
expression and epigenetic marks can be influenced by environmental factors like nutrition 
and toxins and they are inheritable over generations. Especially mother´s diet during early 
pregnancy can impact the embryonic epigenome and the phenotype of the offspring. 
In this experiment cells of the human colon carcinoma line Caco-2 were treated with 
butyrate, genistein, folic acid, zebularine, Epigallocatechin-3-gallate (EGCG), and chrysin. 
Most of these agents are food components and are known to have epigenetic effects on 
gene regulation. After the treatment the gene expression, methylation state and histone 
acetylation of specific sites of the interleukin 8 (IL-8) gene were investigated. IL-8 is an 
inflammatory mediator which induces chemotaxis. Aberrant chemokine expression plays a 
critical role in many inflammatory disorders including chronic inflammatory bowel disease. 
IL-8 is known to be regulated by epigenetic pathways including DNA methylation and histone 
acetylation. Contrary to the most genes the regulatory methylation sites are not in the 
promoter region but about 1.2 kilo bases upstream. 
The study aimed the investigation of the effect of specified nutrients on inflammatory 
mediators on the example of IL-8. 
Gene expression was analyzed by ELISA and real-time PCR, DNA methylation by bisulfite 
sequencing PCR (BSP) and histone acetylation by Chromatin immunoprecipitation (ChIP). 
The results showed that butyrate decreased the methylation grade and increased the 
histone acetylation on histone H3 lysine 9 but no changes in the gene expression could be 
observed. Folic acid enhanced DNA methylation as it was expected but did not alter gene 
expression. Gene expression was increased by genistein, zebularin and chrysin. 
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ZUSAMMENFASSUNG 
Epigenetik ist definiert als Änderungen in der Genexpression ohne Änderung der DNA-
Sequenz und kann zu einer Veränderung des Phänotyps führen. Es gibt drei epigenetische 
Mechanismen: DNA Methylierung, Histonmodifikationen und Wechselwirkungen mit 
kleinen, nicht-codierenden RNAs. Genexpression und epigenetische Marker können von 
Umweltfaktoren wie Ernährung und Toxinen beeinflusst werden. Speziell die Ernährung der 
Mutter in der frühen Schwangerschaft hat Auswirkungen auf das embryonale Epigenom und 
den Phänotyps des Nachwuchses. 
In diesem Experiment wurden Zellen der humanen Colonkrebslinie Caco-2 mit Butyrate, 
Genistein, Folsäure, Zebularin, Epigallocatechin-3-gallat (EGCG) und Chrysin behandelt. Die 
meisten dieser Substanzen sind Nahrungsmittelinhaltsstoffe und haben epigenetisch Effekte 
auf Gene. Die Genexpression, der Methylierungsgrad und die Histonacetylierung an 
bestimmten Stellen des Interleukin 8 (IL-8) Gens wurden an den behandelten Zellen 
untersucht. IL-8 ist ein Entzündungsmediator, der Chemotaxis induziert. Abweichende 
Expression der Chemokine spielt eine kritische Rolle in vielen entzündlichen Erkrankungen 
wie z.B. in chronisch entzündlichen Darmerkrankungen. Es ist bekannt, dass IL-8 über 
epigenetische Mechanismen der DNA Methylierung und Histonacetylierung reguliert wird. 
Im Gegensatz zu den meisten Genen, befinden sich die regulatorischen Methylierungsstellen 
nicht in der Promoterregion sondern ca. 1,2 Kilobasen aufwärts. 
Diese Studie hatte zum Ziel, Effekte von bestimmten Nahrungsstoffen auf 
Entzündungsmediatoren am Beispiel von IL-8 zu untersuchen. 
Genexpression wurde mittels ELISA und real-time PCR, DNA Methylierung mittels bisulfite 
sequencing PCR (BSP) und Histonacetylierung mittels Chromatin Immunopräzipitation 
analysiert. 
Die Resultate zeigten, dass Butyrat den Methylierungsgrad herabsetzte und die 
Histonacetylierung am Histon H3 Lysin 9 steigerte, aber zu keinen Änderungen in der 
Genexpression führte. Folsäure steigerte wie erwartet die DNA Methylierung aber die 
Genexpression wurde ebenfalls nicht verändert. Genistein, Zebularin und Chrysin 
beeinflussten die Genexpression. 
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Abstract 
High ectopic expression of IL-8 associated with changes of methylation in CpG islands or 
histone modification is seen in cells of various tumors and is correlated with metastatic 
potential and tumor growth. This study examined the relevance of methylation of defined 
CpG sites and histone deacetylation as well as food ingredients effecting epigenetic 
pathways for the expression of IL-8 in undifferentiated, preconfluent CACO 2 cells. 
CACO-2 cells were treated with genistein, butyrate, zebularine, folic acid, EGCG, and chrysin 
for 48 hours. We analyzed gene expression by real time PCR, DNA-methylation by bisulfite 
sequencing PCR, and histone acetylation by Chromatin immunoprecipitation. 
Only IL-8 increased IL-8 expression significantly. Folic acid stimulated the IL-8-DNA-
methylation on the sites -1342 and -1412. Butyrate stimulated the histone acetylation on H3 
lysine 9 at IL-8 and demethylated both investigated CpGs. Genistein and butyrate also 
stimulated apoptosis relevant caspase-3. Changes in butyrate producing GI-microbiota 
(Clostridium cluster IX and XIVa) were found due to nutrition. 
These results suggest that DNA methylation of the CpGs at - 1342 and - 1412 bp as well as 
histone modulation participate in the epigenetic control of IL-8 expression and metastatic 
characteristics. Furthermore, dietary strategies may be effective in the modulation of 
multiple inflammatory diseases where IL-8 expression plays an important role. 
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Introduction.  
Expression of chemokines such as Interleukine-8 is pivotal for tumourgenesis and in the 
development of chronic inflammation such as Crohn´s disease and inflammatory bowel 
diseases (Demetter et al., 2000). Gene expression of chemokines is tightly regulated because 
of the potent effects induced by even minute quantities of such proteins in an autocrine, 
paracrine or hormonally derived way (Kitadai et al., 2000; Tuschil et al., 1992; Wen and Wu, 
2001). Under normal conditions, IL-8 expression is restricted to a few kinds of cells including 
monocytes, endothelial cells, epithelial cells and fibroblasts and is stimulated by pro-
inflammatory cytokines, stress and viral infections (Elenkov, 2008; Mastronarde et al., 1996). 
High ectopic expression of IL-8 is seen in several undifferentiated tumour cells and is 
positively correlated with the metastatic potential and tumour growth of melanoma cells, 
lung tumours, breast tumour tissues and colon carcinoma cells (Bar-Eli, 1999; Cheng et al., 
2004; De Larco et al., 2003; Li et al., 2001; Singh et al., 1999). The CACO-2 cell-line is in the 
preconfluent proliferative state relatively undifferentiated and shows ectopic IL-8 expression 
which is inhibited after spontaneous differentiation (Li et al., 2001; Wen and Wu, 2001). 
Activation of IL-8 expression by immune mediators is primarily controlled by a basal 
promoter located immediately upstream of the transcriptional start site which includes four 
cis-regulatory elements: NF-κB at - 82 to - 70, CCAAT/enhancer-binding protein (C/EBP) at -
 94 to - 84, activator protein 1(AP1) at - 126 to - 120 as positive acting elements and Oct-1 at 
- 90 to - 83 as repressor of IL-8 transcription (Fraga et al., 2005; Matsushima et al., 1989). 
Wen et al (Wen and Wu, 2001) demonstrated that in CACO-2 cells, immune-activated 
transcription of the IL-8 gene is silenced upon differentiation through epigenetic histone 
deacetylation by elements located outside of the immediate 5´-flanking region of the gene. 
The same study showed a basal transcriptional repression of the gene by an epigenetic, but 
histone deacetylase independent mechanism that requires elements located several 
kilobases away from the gene locus. In addition modulation of the nuclear factor κB pathway 
by histone deacetylases has been shown to regulate IL-8 expression (Chavey et al., 2008). In 
a study (De Larco et al., 2003), comparing high and low metastatic breast carcinoma cell 
lines, a strong, positive correlation between the methylation status of two CpG sites located 
at - 1342 and - 1412 bp upstream of the transcriptional start site and ectopic expressed IL-8 
mRNA was identified.  
The SCFA butyric acid is produced by the gastrointestinal microbiota through the breakdown 
of non-digestible fibers. The epigenetic effect of butyrate is mainly caused by the non-
competitive inhibition of HDACs, especially class I and II, leading to a histone 
hyperacetylation. An up-regulation of tumor suppressor genes after treatment with butyrate 
has been reported and an increased histone acetylation in the promoters of these genes was 
detected. (Rada-Iglesias et al., 2007) Only the expression of 2 % of all mammalian genes is 
influenced through the HDAC inhibitoring activity of butyrate suggesting the existence of a 
butyrate response element in the promoter regions of the affected genes. (Davie, 2003) In 
concentration from 5 to 100mM butyrate shows apoptotic activity involving the caspase-3-
pathway. (Ruemmele et al., 1999) 
Genistein (4´,5,7-trihydroxyflavone) is an isoflavonoid naturally occurring in soy. (Li et al., 
2001) It modulates the activity of the transcription factors NF-κB and the fork head 
transcription factors (FOXO) influencing apoptosis indirectly. Genistein lowers the expression 
of SIRT1 and so increases the histone acetylation of H3K9 in several gene promoter regions 
like PTEN and FOXO3a. (Kikuno et al., 2008) 
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Folic acid is a water soluble vitamin and is essential for numerous body functions because it 
acts as one-carbon donor, e.g. for SAM. Since cancer cells have aberrant DNA methylation 
pattern folate intake and blood levels in an individual might modify its susceptibility to 
cancer. (Miller et al., 2008) 
Zebularine is a cytidine analog and was originally developed as a cytidine deaminase 
inhibitor. It acts as DNMT inhibitor by forming tight covalent complexes between DNMT 
proteins and zebularine-substituted DNA. (Billam et al., 2009) The incorporation rate was 
higher in cancer cells than in normal fibroblasts. In preliminary experiments the response to 
the treatment was higher in cancer cells. (Cheng et al., 2004) 
Epigallocatechin-3-gallate (EGCG) is the major polyphenol of green tea accounting for more 
than 50 % of all green tea polyphenols. It is known to inhibit the activity of DNMT1. (Berletch 
et al., 2008) EGCG also significant reduced acetylation of histone due to its action as HAT 
inhibitor. Another mechanism induced by EGCG is the suppression of the transcription factor 
NF-κB, which is involved in inflammatory processes. (Choi et al., 2009) 
Chrysin is a flavonoid naturally occurring in many plants, honey, and propolis. It was shown 
to possess antioxidant, anti-allergic, anti-inflammatory, anti-cancer, anti-estrogenic, and 
anxiolytic properties. No epigenetic investigations of chrysin have been published by now. 
But due to the manifold effects shown by chrysin epigenetic pathways and gene regulation 
e.g. for antioxidative genes seem possible. 
In the present work we analyzed the impact of food ingredients on the cytosine methylation 
of the CpGs located at - 1342 and at - 1412 on IL-8 mRNA expression in CACO-2 cells. The 
effects of diets on epigenetic regulation of gene expression was shown by our group before 
(Thaler et al., 2008).  
 
Methods. 
Cell line and culture conditions. The human colon carcinoma cell line CACO-2 was grown in 
six well tissue culture plates and cultured in DMEM media supplemented with 10 % heat-
inactivated foetal bovine serum, 1 % L-Glutamin (200 mM) and 1 % of penicillin- 
streptomycin solution (10 000 U penicillin, 10 mg streptomycin/ml, 0,9 % NaCl) at 37°C in a 
humidified atmosphere of 5 % CO2 in air. Growth medium was replaced every 2-3 days. The 
CACO-2 cells were cultured for 6 days to achieve undifferentiated cells. Cell treatments were 
performed in duplicates with folic acid, vitamin B12, genistein, valproate, valproate plus 
genistein and zebularine respectively at a concentration of 200 μmol/l for 48 hours. Cells 
were washed twice with cooled PBS (4°C) before nucleotide extraction.  
Genomic DNA isolation and bisulfite modification. DNA was isolated from cells using a DNA 
Isolation Kit (Qiagen) and bisulfite conversion for detection of unmethylated cytosines was 
performed using the Epitect Bisulfite Kit (Qiagen). Both kits were used according to the 
manufacturer's instructions.  
Analysis of CpG methylation. Analysis of methylated CpGs was performed by bisulfite 
genomic sequencing PCR (BSP). To increase specificity of PCR after DNA conversion, a nested 
PCR approach was used. Characteristics of the diverse primers are listed in table 1. All 
external PCRs were performed in a 10 µl final volume using the Promega PCR Master Mix, 
(Wisconsin, USA) with the following PCR-conditions: 95°C for 10 min, 35 cycles at 95°C for 30 
sec, 50 sec at a specific temperature and 1 min at 72°C and 5 min at 72°C. For internal PCR, 
samples were diluted 1:100 and amplified with the same master mix in a 50 µl final volume. 
After purification samples were subsequently directly sequenced by an ABI sequencing 
system. Finally, at the interested CpG sites, signal heights were directly compared using the 
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software Sequence Scanner, version 1.0 from Applied Biosystems. No significant differences 
were seen between sequencing of cloned samples compared with directly sequenced 
samples.  
Analysis of gene expression. Total mRNA was extracted from cells using the NucleoSpin RNA 
II Kit (Macherey-Nagel, Dueren, Germany) and reverse transcribed using the single-strand 
cDNA Synthesis Kit (Roche, Mannheim, Germany). Gene expression was performed in 
triplicates by Sybr Green real-time PCR using the Corbett Rotor-Gene 3000. The target mRNA 
expression was normalized to the glucose-6-phosphate dehydrogenase (G6PD) mRNA 
expression which was found to be stable expressed after the listed cell-treatments. The 
primers for gene expression are characterized in table 1. The following thermo-cycling 
conditions were selected: 95°C for 10 minutes followed by 35 cycles at 95°C for 45 sec, 
further 60 sec 66°C and 1 min at 72°C. All reactions were set-up in a 10 μl final volume using 
the master mix SensiMix DNA Kit, (Quantace, London). Optimum reaction conditions were 
obtained with 5 μl 2x PCR master mix, 1 μl of each primer, 2 µl H2O and 2 μl template 
(cDNA). 
Analysis of histone acetylation by Chromatin Immunoprecipitation (ChIP). Cells were 
treated with formaldehyde to crosslink DNA and histones. The complexes were sonicated to 
get fragments of 200 to 600 base pairs length. For immunoprecipitation 4 µg of an antibody 
specific for acetylation on histone H3 lysine 9 (H3K9) was added to each sample and the 
immune complexes were enriched at protein A beads. The DNA was purified out of the 
immune complexes and quantified by real time PCR (primers listed in table 1). 
 
Results. 
IL-8 CpG methylation at - 1342 and - 1412 in CACO-2 cells 
A clear 2.8 fold/3.4 fold hypermethylation was observed after treatment with folic acid on 
CpG-sites -1342/-1412 compared to the untreated cells. Butyrate led to a decrease of the 
methylation grade on the site -1342 to 0.3 and on -1412 to 0.6. Genistein (-1342: 1.1; -1412: 
1.2) and zebularine (-1342: 0.9; -1412: 0.9) showed only slight changes in the methylation 
pattern of both CpG-sites. 
Modifications of epigenetic control of IL-8 gene expression 
In contrast to ELISA results gene expression analysis on the mRNA level showed a 7.4 fold 
enhanced IL-8 expression after cell treatment with genistein. Zebularine (1.6) and Chrysin 
(1.9) lead to a slight increase of IL-8, but no changes could be observed for butyrate (1.1), 
folic acid (1.2), and EGCG (1.3). 
Chromatin Immunoprecipitation of H3K9: 
ChIP was performed with cells after treatment with the HDAC inhibitor butyrate. The 
acetylation of H3K9 was 5.2 fold increased, this was significant (p<0.01). 
 
Discussion 
 
Butyrate 
Butyrate is known as HDAC inhibitor. Thus no changes in the grade of DNA methylation could 
be expected. However, a significant decrease of the methylation state of the two CpG-sites 
on the IL-8 gene was observed. One possible explanation for that might be the apoptotic 
effect of butyrate involving the caspase-3 pathway. Activated caspase-3 cleaves several 
substrates including the DNA repair enzyme pol-(ADP-ribose)polymerase (PARP) leading to 
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DNA breakdown. The decrease in methylation might be due to a beginning degradation of 
the DNA. (Ruemmele et al., 1999) 
Only few studies were made to investigate the influence of butyrate on the methylation 
pattern of genes. In one of these a hypermethylation of the retinoblastoma gene in the 
human colon tumor cell line HT29 was observed. This confirms our findings, which also show 
an effect of butyrate on DNA methylation. (Gope and Gope, 1993) The present findings 
suggest a hypomethylation of the IL-8 gene through butyrate treatment. Further 
investigation will be necessary to prove these results. 
The histone acetylation on H3K9 significantly increased after treatment with butyrate. This 
result was expected because butyrate is known as HDAC inhibitor. Acetylation of the chosen 
site was shown to correlate with the nucleosome structure. Changes in acetylation have 
previously been linked to a change in gene expression. (Michishita et al., 2008; Strasak et al., 
2009) The lysine residue 9 is located at the end of the histone. That is why modifying 
enzymes can easily access this site. The impact of agents on histone acetylation can thus be 
observed on lysine 9 more clearly than on others. Even though only about 2 % of all human 
genes are responsive to butyrate treatment (Davie, 2003) IL-8 is known to be regulated by 
this SCFA. (Chavey et al., 2008; Davie, 2003; Della Ragione et al., 2001). Butyrate acts as a 
non-competitive HDAC inhibitor particularly affecting class I and II HDACs. (Rada-Iglesias et 
al., 2007) 
The IL-8 expression did not show significant changes after butyrate treatment on mRNA or 
protein level in spite of increased histone acetylation. It has been reported that an increased 
mRNA level after butyrate treatment is not only caused by altered histone acetylation state 
but also by post transcriptional events (Hirsch and Bonham, 2004). It is a transient event. 
However, Peart et al. observed that HDAC inhibitor treatment results in an early response of 
gene activation, but gene repression increased over time. After 16 hours of HDAC inhibitor 
treatment more genes were repressed than activated. (Peart et al., 2005) Considering these 
results, it might be possible that peak activation had already been over and thus remained 
undetected after 48 hours. 
Butyrate enhances the rate of apoptosis in a dose and time depending manner. Apoptotic 
effects might have rendered impossible to identify changes in gene expression. At a 
concentration of 5mM, which was used in this experiment, the activity of apoptotic enzyme 
caspase 3 was significantly increased. (Ruemmele et al., 1999) Even though butyrate should 
show decreased IL-8 expression due to its anti-inflammatory properties the opposite was 
reported when the Caco-2 cells were immune activated before the treatment. (Wen and Wu, 
2001) So although other results have been expected, the recent findings can be explained by 
the reasons mentioned above. 
 
Genistein 
Treatment with 200 µmol/l genistein did not result in significant changes in methylation 
pattern of the two investigated CpGs. Li et al. explored the influence of genistein on breast 
cancer cell lines and linked it to telomerase activity. They found a decreased expression of 
DNMTs leading to a hypomethylation of several genes associated with telomerase activity 
and cancer. But this altered methylation pattern could not be seen in all genes determined. 
(Li et al., 2009) 
Another hint of the methylating potential of genistein was shown in the agouti mouse 
model. Supplementation of genistein to the mother´s diet shifted the coat color of the 
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offspring towards pseudoagouti. The methylation grade of the investigated CpGs increased. 
(Dolinoy, 2008) 
Genistein is an anti-inflammatory agent. Decreased IL-8 level as shown by ELISA confirmed 
several previous studies that found a decreased expression. But the mRNA level of IL-8 
increased significantly after genistein treatment for 48 hours. Genistein was seen to slow 
down cell growth in cancer cell lines and hinder DNA synthesis. The increased IL-8 expression 
could thus be a symptom of altered cell cycle and beginning apoptosis. (Handayani et al., 
2006) Another possible explanation might be a generalized inflammatory response of the 
Caco-cells due to the addition of genistein to their media in excess concentrations. 
Genistein regulates gene expression in a very complex way and so the manner how 
transcription is influenced is hard to predict. Despite the effect on the expression of the 
HDAC SIRT1, which is lowered by genistein (Kikuno et al., 2008) and the decreased 
expression of DNMTs (Li et al., 2009) the estrogenic impact of genistein can also alter the 
gene expression. It binds to estrogen receptor alpha (ERα), which acts as a transcription 
factor upon activation. The activated ERα increases the activity of HATs introducing another 
epigenetic mechanism. (Hong et al., 2004) So even though genistein was objective in many 
studies until now, further investigations will be necessary to understand the holistic 
mechanism by which genistein influences human gene expression. 
 
Folic acid 
Folic acid increased the methylation grade of the investigated CpG-sites as expected because 
of its function as methyl group donor. Jang et al. observed cell cultures under condition of 
folate depletion and analyzed their methylation state. They determined a global DNA 
hypomethylation as expected but surprisingly some regions were hypermethylated. For 
example a 5´-CpG island of the H-cadherin gene showed hypermethylation and down 
regulation of gene expression. Presumably, this is a compensatory response. (Jang et al., 
2005) Due to observations in rat liver tissue it was suggested that a hypo- or 
hypermethylation introduced by folic acid acts in a site and gene specific manner. Not all 
responses might be in the same direction. These results were confirmed in cell culture 
studies including Caco-2 cells. Studies in rats showed that DNA hypomethylation did not 
occur in colon-cells by folate deficient diet suggesting that the colorectum may be resistant 
to the hypomethylating effect. It was also suggested that a folate deficiency of a moderate 
degree or short duration induces DNA hypermethylation (as it was seen in rodent liver 
tissue) due to compensatory up regulation of DNMTs. In humans a low folate intake 
decreased the global DNA methylation grade of leukocytes. Colon DNA methylation was 
positively correlated with serum and red blood cell folate concentration and negatively 
correlated with plasma homocysteine. (Kim, 2004b) 
Although in general an increased methylation leads to a decreased gene expression no 
significant alteration in the IL-8 expression was seen on protein or mRNA level. This might be 
due to too short incubation time. Studies in rodents fed a diet deficient in different 
combinations of methyl group donors induced genomic and protoonocogene DNA 
hypomethylation and elevated levels of corresponding mRNAs. (Kim, 2004b) Methylation on 
specific CpG sites regulates gene expression in differentiated way independent from the 
global DNA methylation grade. Cell culture studies showed that folate depletion can lead to 
an up regulation as well as a down regulation of different genes. The expression of genes 
involved in one carbon metabolism is enhanced to compensate the lack of folic acid. (Jang et 
al., 2005) The expression of DNMTs is also up regulated. (Kim, 2004b) In animal studies this 
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response to the folate state of an individual depends on age. Depletion or supplementation 
of folic acid showed an influence of cancerogenisis relevant genes like p53 and ILGF2 
associated with age of the laboratory animals. (Jang et al., 2005) 
Folic acid increases the availability of SAM which is also methyl donor for histone 
methylation enzymes. So it seems possible that not only DNA methylation affects gene 
expression after folate treatment but also epigenetic pathways caused by altered histone 
methylation. Due to the concentration and duration of folic acid treatment in this 
experiment this histone effect might abolish the effect of DNA methylation on gene 
expression. 
 
Zebularine 
Although zebularine is a known DNMT inhibitor, no significant changes of the methylation 
state on the investigated CpGs could be seen. This might be due to an improper duration of 
treatment because in several studies alterations of DNA methylation could only be observed 
after more than two days. (Billam et al., 2009; Marquez et al., 2005) The following 
mechanism must also be considered: DNMTs are posttranscriptionally trapped by zebularine 
with DNMT1 as special target. DNMT3a and DNMT3b are just partially reduced. Since DNA is 
not actively demethylated by zebularine, treated cells may still retain substantial 
methylation patterns. (Billam et al., 2009) 
Even though an increase of IL-8 protein could be observed in the ELISA test, no significant 
change was found on the mRNA level. This result is not surprising because no change in DNA 
methylation has been determined. The effect of zebularine an expression of the tumor 
suppressor gene p16 was found to depend on the investigated cell line. So perhaps even 
though the Caco-2 cell line is a cancer cell line, its response to zebularine treatment is 
weaker compared to other cancer cells. (Cheng et al., 2004) Zebularine does not only alter 
gene expression via its influence on DNA methylation. It is assumed that zebularine 
reactivates silenced genes through an enrichment of histone acetylation on promoter 
regions. (Billam et al., 2009) 
 
Epigallocatechin-3-gallate (EGCG) 
EGCG can affect gene expression through several epigenetic mechanisms mentioned in 
introduction. But no significant changes were seen either in the ELISA test or on mRNA level. 
The reasons could be manifold. The incubation time might be too short to see any effects. In 
a study of Fang et al. the mRNA levels after treatment with EGCG started to rise after 72 to 
144 hours depending on the gene although an altered methylation pattern could already be 
seen after 48 hours. (Fang et al., 2007) One pathway by which EGCG acts is the 
demethylation of E2F-1 binding sites and enhanced binding of this transcription repressor. 
(Berletch et al., 2008) This regulatory pathway might not be involved in the IL-8 gene at all. 
This might explain unchanged IL-8 gene expression. Due to the inhibition of NF-κB by EGCG 
gene relevant in inflammatory, e.g. IL-6, processes showed reduced expression after 
treatment. (Choi et al., 2009) No such effect was seen in this study but the effects of EGCG 
were described as cell line and gene specific. (Fang et al., 2007) 
 
Chrysin 
Epigenetic gene regulation by chrysin seems possible due to its manifold effects. It was 
described as an antioxidant, anti-allergic, anti-inflammatory, anti-cancer, anti-estrogenic, 
and anxiolytic agent. (Sathiavelu et al., 2009) Chrysin treatment of Caco-2 cells in 50 µmol/l 
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caused a significant increase of IL-8 protein abundance but only a slight increase in mRNA. 
These results are contradictory to the postulated anti-inflammatory properties of chrysin. 
Anyhow, anti-inflammatory effects cannot be explained by a single regulator. The reaction of 
Caco cells to treatment with chrysin might also be due to a slightly toxic effect of the 
treatment. Since no epigenetic investigations with chrysin were published till now further 
research might be necessary to determine physiological treatment conditions. 
 
In conclusion our results suggest that DNA methylation of various CpGs as well as histone 
modulation participates in the epigenetic control of IL-8 expression and that dietary 
strategies may be effective in the modulation of multiple inflammatory diseases where IL-8 
expression plays an important role. 
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7.2. Book chapter 
for the book “Epigenetics and Human Health, Linking hereditary, environmental and 
nutritional aspects” (Editor: Dr. Alexander Haslberger) 
 
Interaction of hereditary and epigenetic mechanisms in the regulation of immune and 
aging relevant gene expression 
 
Roman Thaler, Eva Aumüller, Carolin Berner, Judith Schuster, Alexander G. Haslberger 
Department for Nutritional Sciences, University of Vienna 
 
Abstract Hereditary dispositions and environmental factors such as nutrition, natural and 
societal environment interact on human health. Diet compounds rise increasing interest due 
to their influence in co-regulating epigenetic gene expression. Nutrition and specific food 
ingredients have been shown to alter epigenetic markers such as DNA methylation or 
histone acetylation involving regulation of genes with relevance for fundamental 
mechanisms such as antioxidative control,  cell cycle regulation or expression of immune 
mediators.  
 
Hereditary dispositions  
Interactions between genes and environment are not linear and often include direct and 
indirect cause of events. Many complex diseases are linked to various heritable dispositions 
like single nucleotide polymorphisms (SNP) or allelic translocations. Consequently they have 
become a main focus in modern biomedical research and also started to raise public 
interest. Single nucleotide polymorphisms are common rather than exceptions. SNP´s may 
determine the efficiency of gene transcription, gene translation or protein structure, leading 
to an altered amount of enzyme and/or –activity, thus influencing further metabolic 
pathways. A SNP can occur within coding sequences of genes, non-coding regions of genes 
or in intergenic regions. SNPs within a coding sequence do not necessarily change the 
functional efficiency of the protein (silent mutations) (Nothnagel et al., 2008) (Haiman and 
Stram, 2008). 
Upon completion of the human genome project it was confirmed that 99.9 percent of the 
human genome's 3 million base pairs are identical in any person. The remaining 0.1 percent, 
(mainly SNPs) are assumed to play a key role in congenital sensitivity to disease and drug 
side effects. They also appear to influence peoples' variable responses to pharmaceuticals or 
different penetrance of the same disease. The International HapMap (haplotype map) 
Project aimed to study the scope of these SNP variations in different population groups. 
Clusters of SNPs located on the same chromosome tend to be inherited in blocks. It is 
expected that the outcomes of this project will provide crucial tools that allow researchers 
to detect genetic variations with effects on health and disease. In so called genome-wide 
association studies, researchers compare genomes of individuals with known diseases to a 
control group of healthy ones in order to detect suspicious tag SNPs which might play a role 
in development/genesis or course of disease. ( HapMap project, http://snp.cshl.org/ ) 
A variety of functional SNPs on several genes, covering almost all aspects for cell viability, is 
well described in literature. In superoxide metabolism for example, an increase in 
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superoxide radicals is given by the SNP (rs4880) regarding the mitochondrial Superoxide 
Dismutase (MnSOD) gene (Taufer et al., 2005). Several kinds of cancer (Kang et al., 2007), 
Alzheimer disease (Wiener et al., 2007), as well as an accelerated aging process are 
discussed to be related to this SNP. In opposite, three SNPs in the human forkhead box O3A 
gene (FOXO3A) were statistically significantly associated with longevity. Polymorphisms in 
this gene were indeed associated with the ability to attain exceptional old age, the FOXO3A 
association was considerably stronger in centenarians than in nonagenarians. In nutritional 
sciences, the methylenetetrahydrofolatereductase (MTHFR) gene is well known as it is 
essential for folic acid metabolism (Miyaki et al., 2008). The polymorphism C677T in the 
MTHFR gene is discussed to have an influence in several methylation pathways as for 
example in the DNA –methylation pathway.  
So far, a multitude of ailments have been correlated with  their respective SNPs.  Yet, the 
predictability for the development of diseases from the analysis of SNPs still requires larger 
controlled studies. The present difficulty in utilizing SNPs analysis arises from missing the 
functional relevance of many SNPs. In addition, the mostly small and variable penetrance of 
single SNPs leads to statistical limitations and poor reproducibility in many clinical studies 
associating SNPs and diseases (Janssens et al., 2008). 
The combination of an individual’s relevant SNPs in addition to environmental influences 
may define his risk for developing diseases. Sets of candidate SNPs  and experiences from  
the analysis of  the work with biobanks need  to be evaluated to understand  gene – 
environment interactions (Vineis et al., 2007). 
The epigenome  
Despite of the genetic code, mammalian cells contain an additional regulatory level which 
predominates over the DNA code: modification of gene expression by altering chromatin. 
Thus, due to different chromatin status, same genetic variants might be for example 
associated with opposite phenotypes depending on different environmental influences. New 
insights in research clarify the molecular pathways by which, amongst others, nutrition and 
lifestyle factors influence chromatin packaging and further health status. Indeed several 
studies clearly correlate the risk for developing multifactorial chronic diseases like cancer, 
diabetes or obesity with nutritional and lifestyle habits (Jirtle and Skinner, 2007; Johanning 
et al., 2002; Mann et al., 1999; Tsugane and Sasazuki, 2007). 
Measurable consequences of these influences are alterations in the expression of a growing 
number of genes, caused by remodeling of chromatin and DNA methylation. Methylation of 
cytosines in DNA, histone modifications as well as alterations in the expression level of micro 
RNA (miRNA) and short interference RNA (siRNA) are the mechanisms involved in chromatin 
remodelling. This topic is being studied by the fast evolving research area of epigenetics. The 
term "epigenome" is used to define a cell's overall epigenetic state. Epigenetic modifications 
can be stably passed over numerous cycles of cell division. Some epigenetic alterations can 
even be inherited from one generation to the next (Anway et al., 2006b; Dolinoy et al., 
2006b). Studies conducted by the Department of Community Medicine and Rehabilitation of 
the Umeå University in Sweden showed transgenerational effects due to nutritional habits 
during a child's slow growth period (SGP), the phase of the prepubertal peak in growth 
velocity. Clear correlations with descendants' risk of death from cardiovascular disease and 
diabetes were also seen (Kaati et al., 2002). The finding that monozygotic twins are 
epigenetically indistinguishable early in life but, with age exhibit substantial differences in 
the epigenome, indicates that environmentally determined alterations in a cell's epigenetic 
markers might be responsible (Fraga et al., 2005). 
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During the development of germ cells and during early embryogenesis DNA is specifically 
methylated and these markers confer genome stability, imprinting of genes, totipotency, 
correct initiation of embryonic gene expression and early lineage development of the 
embryo (Morgan et al., 2005). According to experiments in the Agouti mouse model, early 
epigenetic programming is alterable through mothers' diet during pregnancy, leading to 
lifelong modification of selected genes for the offspring (Dolinoy et al., 2007). Thorough 
knowledge of both epigenetic and classic genetic code is necessary in order to truly 
understand interactions between the environment and gene expression. 
Epigenetic mechanisms 
Epigenetic regulation includes DNA methylation, histone modifications and post-
transcriptional alteration of gene expression based on microRNA interference. 
Methylation  
Basic biological properties of segments such as gene density, replication timing and 
recombination are tightly linked to their guanine –cytosine (CG) content, therefore isochors 
(DNA fractions > 300 kb on average) of the genome can be classified accordingly (Costantini 
et al., 2006). CpG islands are defined as genomic regions with a GC percentage greater than 
50% and with an observed/expected CpG(cytosine base followed by a guanine base) ratio 
greater than 60 %. In mammals, CpG islands typically are 200-3.000 base pairs long. CpGs are 
rare in vertebrate DNA due to the tendency of such arrangements to methylate cytosines to 
5-methylcytosines followed by a turn into thymines because of spontaneous deamination. 
The same mechanism seems to be responsible for the inactivation of retroviruses by 
changing the virus sequences [17]. 
The consequences are large DNA -regions low in GC and gene density, clearly visible on 
isochore maps as “genome deserts”. However, some regions escaped large scale 
methylation and determination during evolution and, therefore, show a high amount of GCs, 
which is generally parallel to a high CpG island and gene density (16). CpG islands mostly 
occur in these isochors, at or near the gene's transcriptional start site. Promoters of tissue-
specific genes that are situated within CpG islands normally are largely unmethylated in 
expressing and non-expressing tissues (Bestor, 2000). There are three known ways by which 
cytosine methylation can regulate gene expression: first 5-methylcytosine can inhibit or 
hinder the association of some transcriptional factors with their cognate DNA recognition 
sequences, second methyl-CpG-binding proteins (MBPs) bind to methylated cytosines 
mediating a repressive signal and third MBPs can interatct with chromatin forming proteins 
modifying surrounding chromatin, linking DNA methylation with chromatin modification 
(Klose and Bird, 2006). Mostly DNA methylation cause a repression of mRNA gene 
expression, however, when CpG methylation blocks a repressor binding site within a gene 
promoter, this may induce a transcriptional activation as shown for Interleukin-8 in breast 
cancer (De Larco et al., 2003) 
DNA -methylation at position five of CpG-cytosines is conducted by DNA methyltransferases 
(DNMT’s), which are expressed in most dividing cells (Schaefer et al., 2007). Mammalian 
DNMT’s can be divided in two general classes. DNMT1 enzyme is responsible for the 
maintenance of global methylation patterns on DNA. It preferentially methylates CpGs on 
hemimethylated DNA (CpG methylation on one site of both DNA strands), therefore 
guaranteeing transfer of methylation marks through the cell cycle in eukaryotic cells. The 
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DNMT1 enzyme is directly incorporated in the DNA replication complex. The de novo 
methyltransferases DNMT3a and DNMT3b establish methylation patterns at previously 
unmethylated CpGs. DNMT3L is a DNMT related enzyme which associates with DNMT3a/3b. 
It influences its enzymatic activity while lacking one of its own. Finally, for the DNMT2 
enzyme, in mammals a biological function remains to be demonstrated (Bestor, 2000; 
Schaefer et al., 2007). Specific mutations in the DNMT3b gene were found in patients 
affected by the autosomal recessive immune disorder ICF. 
Most DNMT’s contain a sex-specific germline promoter which is activated at specific stages 
during gametogenesis. Genomic methylation patterns are largely erased during proliferation 
and migration of primordial germ cells and reestablished in a sex-specific manner during 
gametogenesis, resulting in a high methylation of the genome. For viability, close regulation 
of the DNMT genes during these stages and during early embryogenesis is needed (Schaefer 
et al., 2007). After fertilization a second phase of large epigenetic reprogramming takes 
place. Upon fertilization, a strong, presumably active DNA demethylation can be observed in 
the male pronucleus while the maternal genome is slowly and passively demethylated. 
Imprinted methylation is maintained for both the paternal and the maternal genome. DNA-
demethylation occurs until the morula stage, after which de novo methylation is observed 
(Dean et al., 2003). See figure 1, adapted from Morgan et al 2005 and Dean et al 2003 (Dean 
et al., 2003; Morgan et al., 2005). 
For targeting DNA de-novo methylation, three mechanisms are described. First, DNMT3 
enzymes themselves might recognize DNA or chromatin via their conserved PWWP 
(relatively well-conserved Pro-Trp-Trp-Pro residues, present in all eukaryotes) domain. 
Mouse experiments show that this domain is necessary for targeting the enzyme to 
pericentromeric heterochromatin. In humans, mutations in the PWWP domain can cause ICF 
syndrome Immunodeficiency, Centromere instability and Facial anomalies syndrome). 
Second, by interaction of DNMT’s with site-specific transcriptional repressor proteins 
DNMT’s can be targeted to gene promoter regions. Third, in vitro studies have shown that 
introduction of double stranded RNA corresponding to the promoter region of the target 
gene leads to its de-novo DNA methylation and decreased gene expression, suggesting the 
existence of an RNAi mediated DNA methylation mechanism. However, further efforts are 
needed to clarify this pathway (Klose and Bird, 2006). 
Their catalytic role aside, DNMTs seem to mediate gene silencing by modifying chromatin via 
protein-protein interactions. They biochemically interact with histone methyltransferases 
(HAT) and histone deacetylases (HDACs). As mentioned above, binding of MBP’s to 
methylated CpGs mediates silencing of gene expression by the associaton with chromatin 
remodeling co-repressor complexes. Thus, under certain circumstances, gene silencing by 
DNA methylation may be attributed directly to chromatin modifications. So far, six different 
methyl-CpG- binding domains (MBD) are known for the MBPs: MBD1 to 4, MeCP2 and Kaiso. 
All of them mediate silencing of gene expression by chromatin remodeling (Clouaire and 
Stancheva, 2008). For example, the MBD1 and a histone H3 methyltransferase enzyme 
(SetDB1) interact during the cell cycle, linking DNA methylation to rearrangement of 
chromatin by histone methylation (Klose and Bird, 2006). Even if no active demethylation for 
DNA is known, gene silencing by DNA methylation is not irreversible. For example, Il-4 
expression in undifferentiated T cells is silenced via binding of MBD2 on the methylated 
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promoter of the gene (Hutchins et al., 2002). After differentiation, TH2 cells express the 
transcription factor GATA-3 which competes with MBD2 for binding to the IL-4 promoter. In 
this case epigenetic factors impose a threshold to be overcome in order to achieve efficient 
gene expression. The binding of MBDs to DNA seems to be for the most domains sequence 
specific. 
In order to achieve DNA methylation, often alterations at the chromatin level must occur 
before. As previously discussed, DNMTs interact with HATs and HDACs. Small modifications 
of histones by acetylation, methylation, phosphorylation and ubiquitation on certain amino 
acids can alter gene expression by chromatin remodeling. The effect of these small 
modifications on chromatin remodeling depends by type, amount and site of modification as 
well as the interactions as shown in table 1 (adapted from He and Lehming 2003 (He and 
Lehming, 2003)).  
Histone modifications 
Some modifications, including acetylation and phosphorylation, are reversible and dynamic, 
others, such as methylation, are found to be more stable and involved in long term 
alterations (Cheung and Lau, 2005; Shahbazian and Grunstein, 2007).  
As an attempt to organize the complexity of the different possible modifications, the 
establishment of a “histone code” is a major focus of epigenetic research. Its necessity is 
demonstrated in the following example: We know 24 methylation sites on a histone. The 
possibility of mono-, di-, or trimethylated lysine residues and mono- or dimethylated 
arginine side chains lead to 3x1011 different histone methylation states. The need to 
distinguish between short-term changes in histone modification associated with ongoing 
processes and changes that have long term effects still pose a problem to be solved (Turner, 
2000; Turner, 2002). The significance of some histone modifications has been identified, 
especially regarding acetylation and deacetylation of histones (Shahbazian and Grunstein, 
2007). Histone acetylation is the major factor regulating the degree of chromatin folding, 
global loss of monoacetylation and trimethylation at histone H4, all of which are commonly 
seen in human tumor cells. Histone acetylation also regulates nucleosome assembly. 
Over time, the relationship between DNA-methylation and histone modifications will 
become clearer (Cheung and Lau, 2005; Klose and Bird, 2006). Several factors are involved in 
the process of gene silencing by DNA-methylation. One prerequisite is attributed to the 
recruitment of HDACs through the methyl-DNA binding motifs, while methylation at Lys9 on 
H3 is another prerequisite. Methylation of both DNA and histones seem to have a 
reciprocative reinforcing effect in gene silencing. Histone variants like macro H2A, 
accumulated on the inactive X chromosome, have been reported to play a role in gene 
expression regulation. Their presence in the IL-8 promoter-region is connected to tissue 
related gene silencing of the IL-8 gene (30). The comprehension of a histone code will be an 
important step towards in understanding further mechanisms for epigenetic gene 
expression. 
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Histone Modification Effect 
H1 Phosphorylation Chromatin condensation, gene 
specific condensation and repression. 
 Ubiquitination Transcriptional activation 
H2A Acetylation Transcriptional activation 
 Ubiquitination Elusive 
H2B Ubiquitination Prerequisite of H3 methylation 
 Phosphorylation Chromatin condensation 
 Acetylation Chromatin remodeling 
 Methylation Chromatin stabilization 
H3 Methylation (H3-K4, R17) Transcriptional activation 
 Methylation (H3-K9, K79) Transcriptional repression 
 Acetylation Transcriptional activation 
 Phosphorylation Chromatin condensation; 
transcriptional activation 
 Ubiquitination Nucleosome loosening 
H4 Acetylation Transcriptional activation 
 Methylation (H4-K20) Transcriptional repression 
 Methylation (H4-R3) Transcriptional activation 
Table 1: Consequence of histone modifications on chromatin 
Through alteration of gene expression and destabilization of chromatin histone 
modifications can have an impact on the risk of cancer. Modified cancer pathogenesis is 
linked to varying activities of both HATs and HDACs. This mechanism is best described for 
acute promyelocytic leukemias, where a chromosomal translocation leads to inappropriate 
HDACs activity. A change in HDACs expression was also detected in other types of tumors. 
For example, in gastric cancer, esophageal squamous cell carcinoma, and prostate cancer an 
increased HADC1 expression is related to pathogenesis. In contrast, in colon cancer an 
overexpression of HDAC2 causes a decreased expression of the APC (adenomatous polyposis 
coli) tumor suppressor gene. Another way of influencing the expression of tumor suppressor 
genes are abnormal functions of HDACs, for instance by atypical targeting. These 
observations lead to the current exploration of HDAC inhibitors as anticancer therapeutics. 
The examined substances aim to shift several cell functions which are known to be down 
regulated in cancer cells. Among other presumed advantages of the approach show cancer 
cells' an increased sensitivity for HDAC inhibitors compared to normal cells, thus there may 
be a possibility to prevent or to decelerate the development of tumours by such substances. 
Overall, the broad range of function promises efficacy at all stages of tumorigenesis.  
Not only HDACs but also HATs influence the risk of developing cancer. Especially in cancer of 
epithelial origin an overexpression or mutation of HAT genes has been detected. Some lines 
of lung, breast, and colorectal cancer have in common a mutation which inactivates a 
specific HAT.  
Changes of the methylation status of histones have also been observed in some types of 
cancer. The loss of the trimethylated form of the lysine 20 residue of the H4 histone is 
characteristic for cancer cells. Also, the demethylation of lysine 9 on H3 histones increase 
the formation of B-cell lymphoma in mice significantly because of its links to chromatin 
silencing. (Davis and Ross, 2007) 
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Micro RNAs. 
In addition to DNA and Histone modifications, micro RNAs are part of the epigenetic gene 
expression regulatory complex. MicroRNAs are small non-coding RNAs that 
posttranscriptionally regulate the expression of complementary messenger RNAs and 
function as key controllers in a countless number of cellular processes, including 
proliferation, differentiation and apoptosis. Over the last few years, increasing evidence has 
indicated a substantial number of microRNA genes to be subjected to epigenetic alterations, 
resulting in aberrant patterns of expression upon the occurrence of cancer (Guil and Esteller, 
2009) 
Environmental influences 
Early life conditions 
By now, various findings showing the effects of environmental factors on the epigenetic 
regulation of gene expression derive largely from mouse experiments. Environmental factors 
influencing epigenetic gene regulation include more than epigenetically active natural food 
compounds such as vitamin B12 or genistein. Transgenerational effects are for example 
caused by environmental toxins such as the endocrine disruptor vinclozolin, a common 
fungicide used in vineyards. Vinclozolin were seen to disrupt epigenetically the germ line in 
mice. These effects were transferred through the male germ line for several generations. 
The described mechanism appears to be attributed to a heritable alteration of epigenetic 
programming of DNA-methylation in the germ line, which alters the transcriptomes of 
developing organs, in this case the testis development (Anway et al., 2006a). 
Early mammalian development is a crucial period for establishing and maintaining epigenetic 
markers. Modifications of the epigenome are not limited to the fetal period but extended to 
the plastic phase of early life. Broad epigenetic reprogramming can be seen after fertilization 
to achieve totipotency of developing embryo cells, while methylation patterns associated 
with imprinting are sustained. Epigenetic modifications settled during fetal development are 
generally stable passed through cell division processes throughout a lifetime.  
Prenatal exposure to famine for instance, as shown in an epidemiological study, is also likely 
to change the epigenetic status. Observed individuals showed less DNA methylation of 
imprinted IGF-2 gene than their unexposed same sexed siblings (Heijmans et al., 2008). A 
further, nutrition-related epigenetic alteration have been demonstrated in the viable yellow 
Agouti (=Avy) mouse model (Dolinoy et al., 2006a). Maternal diet containing bisphenol A 
(BPA), an estrogenic monomer used in polycarbonate plastic production, significantly 
decreases offsprings methylation of the Avy gene promoter which induces reversal to a wild-
type phenotype. Maternal nutritional supplementation with methyl-donors counteracts the 
effects from BPA, showing that simple dietary changes may protect against harmful 
epigenetical effects caused by environmental toxins. 
Modified promoter methylation and, accordingly, modified gene expression of the hepatic 
glucocorticoid receptor and the peroxisome proliferator –activated receptor alpha (PPAR 
alpha), both important elements in carbohydrate and lipid metabolism regulation, can be 
seen in the offspring of rats fed a protein restricted diet. The selective methylation of PPAR 
73 PUBLICATIONS 
 
alpha in the liver without consequences for the related transcription factor PPAR gamma 
demonstrates that maternal nutrition and behavior can also influence specific promoter 
regions rather than being associated with global DNA -methylation alteration. Such changes 
in gene expression and promoter methylation were also seen to be transmitted to the next 
generation without further nutritional challenge for the first generation (Gluckman et al., 
2007). 
Finally, the elucidation of the impact of epigenetic modifications on behaviour and psychic 
health presents an intriguing challenge. Rodents experiments show that some epigenetic 
changes can be induced promptly after birth through mother’s physical behaviour toward 
her newborn (Darnaudery and Maccari, 2008; Henry et al., 1994; Zuena et al., 2008) Licked 
and groomed newborns appear to grow up to be relatively brave and calm. In contrast, 
neglected newborns grow up to be nervous and hyperactive. The difference in their 
behaviour can be explained by analyzing specific regions in the brain. The hippocampus of 
both groups reveal different DNA-methylation patterns for specific genes agreeing with the 
difference in behaviour. This entails a better developing of the hippocampus in the licked 
newborns, possibly by releasing less of the stress hormone cortisol. Furthermore, recent 
research results have demonstrated that complex epigenetic mechanisms have long-lasting 
effects in mature neurons and that they possibly play a vital role in the etiology of major 
psychoses, such as schizophrenia or bipolar disorder. Paternal age at conception is a strong 
risk factor for schizophrenia, explaining about a quarter of all cases. The possible 
mechanisms for the elevated risk may be de novo point mutations or defective epigenetic 
regulation of paternal genes. The risk might also be related to paternal toxic exposures, 
nutritional deficiencies, suboptimal DNA repair enzymes or other factors that influence the 
reliability of the transfer of genetic information in the constantly replicating male germ line.  
 
Pollution, Toxins 
There is now a mounting body of evidence that environmental exposures to toxins, 
particularly during early development, can induce epigenetic changes, which may be 
transmitted to subsequent generations or serve as basis for diseases developed later in life. 
Either way, epigenetic mechanisms will help interpreting toxicogenomic approaches 
(Reamon-Buettner et al., 2008).  
Air pollution, for instance, particular matters and cigarette smoke, appear to have 
omnipresent toxicological influences on humans. Promotor hypermethylation in early 
tumorigenesis is likely to have a clinical importance, because dissentient promoter 
methylation in tumor suppressor genes has been detected in a large percentage of human 
lung cancers. Noticeably the p16 gene, which expresses an inhibitor of cyclin dependent 
kinase 4 and 6 consequently, interrupting the cell cycle progression is methylated at its 
promoter region in 20-65% of the lung tumors. (Hayslip and Montero, 2006) Smoking habits 
alter the extent of promoter methylation patterns. Increasing methylation of p16 could be 
seen with increasing smoking duration, packets per years and smoking when a juvenile, 
whereas methylation decreases gradually over time when a person quits smoking.  
Similar effects could be seen in rodents' lung cancer, induced by particulate carcinogens 
carbon black and diesel exhaust, where the tumor cells showed an overmethylation in the 
p16 promoter region. Equal circumstances could be found in murine lung tumors, caused by 
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cigarette smoke. Remarkable effects improvements could be achieved by treating rodents 
with histone deacetylation inhibitors in a lung cancer mouse model. A greater than 50 % 
reduction of tumor growth was seen in treated mice. 
In addition to well-known carcinogens, air pollution components and particulate matter 
(PM10), nickel and beryllium compounds have also been shown to also have an impact on 
histone acetylation and/or altered DNA methylation patterns (Vineis et al., 2006).  
Diets  
Dietary habits as well as a sedentary lifestyle clearly contribute to today’s increasing number 
of chronic diseases. The influence played by numerous food compounds on the epigenetic 
machinery is of growing interest. The large number of established and probable epigenetic 
active compounds found in food will challenge the understanding of how diet may influence 
epigenetic gene expression. Studies of dietary effects on epigenetic gene regulation are still 
in their infancy, but first results are shown (Thaler et al., 2008). Food contains compounds 
influencing both, DNA methylation and histone modifications. However, the consumption of 
some of these compounds can vary by season, dietary habits, age and environment.  
Dietary compounds like vitamin B12 or folic acid are implicated in the regulation of the 
cytosine methylation pathway (Choi et al., 2004; Kim, 2004a; Stempak, 2002). Vitamin B12 
plays a central role as it acts as co-factor of the methionine synthetase, remethylating 
homocysteine to methionine. Methionine is further activated to S-adenosylmethionine 
(SAM), the methyl donor for DNA methylation. SAM converts to S-adenosylhomocysteine 
(SAH) after DNA-methylation. Reversible hydrolysis of SAH to homocysteine completes the 
cycle (figure 2, adapted from Kim 2004 (Kim, 2004a)). Folate, cholin or betaine are potent 
methyl-donors directly implicated in the DNA-methylation pathway. However, under 
conditions of vitamin B12 depletion, cellular folate accumulates in the methylfolate form due 
to activity of methionine synthetase being blocked, thereby creating a conditional form of 
folate deficiency. Deficiency in vitamin B12 leads also to an accumulation of serum 
homocysteine. Under conditions of elevated homocysteine concentrations, levels of the 
potent SAM–inhibitor SAH represses DNA methylation. The role of folate in DNA-
methylation seems to be rather complex. Evidence from animal, human, and in vitro studies 
suggest that folate-dependent DNA methylation is highly complex, gene and site 
specific(Cravo et al., 1994; Kim, 2004a; Kim et al., 2001; Rampersaud et al., 2000). These 
studies have shown that the extent and direction of changes in SAM and SAH in cell lines in 
response to folate deficiency are cell specific and that genomic-site and gene-specific DNA 
demethylation are not affected by the changes in SAM and SAH induced by folate depletion. 
Transgenerational studies on a rat model could furthermore demonstrate that folate 
deficiency during pregnancy impacts on methyl metabolism, but does not effect global DNA 
methylation in rat foeti (Maloney et al., 2007). A study analyzing the expression of the 
antioxidative enzyme mitochondrial superoxide dismutase (MnSOD) showed that this gene is 
expressed differently in vegetarians and omnivores due to different DNA-methylation 
patterns in the MnSOD promoter region: vegetarians expressed a significant higher amount 
of MnSOD, showing a low promoter methylation for this gene. Inversely, a lower MnSOD 
expression by a higher MnSOD promoter methylation was seen in omnivores (Thaler et al., 
2008). Several factors which may reduce DNA–methylation machinery in vegetarians are 
discussed. Studies analyzing the B-vitamin status of vegans and vegetarians compared with 
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omnivores, showed generally a higher dietary supply of folate and a lower dietary supply of 
vitamin B12 (since vitamin B12 intake comes predominantly from animal food products) and 
methionine for vegetarians and vegans (Majchrzak et al., 2006; Millet et al., 1989). 
Correlations between plasma folate and vitamin B12 values were found and study findings 
showed that vegetarians and vegans show higher plasma homocysteine concentrations 
(Majchrzak et al., 2006). Furthermore, DNA hypomethylation due to high homocysteine 
levels has been reported in vitro and in vivo (Jamaluddin et al., 2007; Jiang et al., 2007). 
Inhibition of DNA methyltransferase 1 activity by 30% and reduced binding of methyl CpG 
binding protein 2 have also been seen in this context. A further study (Geisel et al., 2005) 
comparing vegetarians and omnivores observed a reverse correlation between SAH 
concentrations and DNA global methylation levels in blood. However, this study was unable 
to correlate homocysteine concentrations with the degree of DNA global methylation and 
found no correlation between the degree of CpG methylation of the promoter of the p66Shc 
gene (involved in oxidative stress) and homocysteine, or SAM or SAH levels.  
Other diet derived factors such as diallyl sulfide (Mathers, 2006), an organosulfur compound 
found in garlic, genisteine, the main flavanoid in soy (Dolinoy et al., 2006b), vitamin D3 or all-
trans-retinoic-acids (Krawczyk and Fabianowska-Majewska, 2006) have been shown to 
influence DNA methylation by altering histones and chromatin structure. On the histone 
level, much more food compounds show effects on epigenetic gene regulation. Food 
compounds acting as histone modifiers are generally weak enzyme ligands and thus are 
needed in high concentrations to generate a consistent effect and therefore might subtly 
regulate gene expression (Dashwood et al., 2006). A number of dietary agents are discussed 
to have a role in epigenetics as HDAC inhibitors. In the literature well described agents in this 
context are butyrate, diallyl disulfide or sulforaphane. Butyrate is the smallest known HDAC 
inhibitor, and inhibits histone acetylation at high micromolar or low millimolar 
concentrations in vitro, levels nonetheless considered to be achievable in the gastro 
intestinal tract by bacterial metabolism (Dashwood et al., 2006). Intriguing examples for a 
HDAC inhibitor are conjugated linoleic acids (CLA), which have anticancerogenic and 
antiatherogenic properties. Interestingly, CLAs decreases Bcl-2 and induces p21, a known 
HDAC target. Effects of CLAs on HDACs are discussed. Regarding the short chain fatty acids 
(SCFs) resulting from the microbial fermentation of dietary fibers, acetate, propionate and 
butyrate are taken up by the colonic mucosa. Butyrate is the preferred energy source for 
colonocytes and is transported across the epithelium. Butyrate, and to a lesser extent other 
SCFs, influence gene expression and inflammation primarily through its action as an inhibitor 
of histone deacetylases. Therefore, diet compounds, toxins or medications interfering with 
the colonic fermentation may also modulate potential epigenetic effects generated by the 
microbial flora. By now, there is much work to be done to clarify the influence on histone 
modifications of a great number of dietary factors, alone or in combination and their tissue 
specific characteristics. A list of discussed dietary HDAC activity modulators is shown in table 
2. 
 
Evidences show that a diet rich in vegetables and fruits might prevent some kind of cancers 
(Research, 2007). In this context, the role of flavonoids is often discussed. Flavonoids can act 
either in a pro- or antioxidative manner depending on their structure and characters. 
Because of the antioxidative properties of some flavonoids, oxidative damage of DNA can be 
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prevented and cancerogenesis altered. Guarrera et al postulated recently that flavonoids 
might influence the gene expression of DNA repair genes, which could be a possible 
explanation for the decrease in tumour development (Guarrera et al., 2007).  
In many animal models caloric restriction has been shown to prevent the development of 
cancer, Thereby the role of sirtuins becomes clearer. In higher eukaryotes, HDACs are 
grouped in four classes (I-IV). Class I of HDACs are found exclusively in the nucleus, whereas 
class II of HDACs shuttle between nucleus and cytoplasm. Resveratrol activates the HDAC 
sirtuin 1 (SIRT1) a HDAC belonging to class III HDACs. Because of their homology to yeast 
sir2, class III HDACs belong to the sir2 family (Davis and Ross, 2007). SIRT is an abbreviation 
for silent mating type information regulation two and there are seven groups in humans 
(Davis and Ross, 2007). Sirtuins are nicotineamide adenine dinucleotide (NAD(+)) dependent 
deacetylases which exhibit a well-defined regression during aging that is dramatically 
reverted in transformed cells. . 
Another group of diet related epigenetic active compounds comprise short chain fatty acids 
(SCFs) resulting from the fermentation of dietary fibers. Acetate, propionate and butyrate 
are taken up by the colonic mucosa. Butyrate is the preferred energy source for colonocytes 
and is transported across the epithelium. Butyrate, and to a lesser extent other SCFs, 
influence gene expression and inflammation primarily through its action as an inhibitor of 
histone deacetylases. Therefore, diets, toxins or medications interfering with the colonic 
fermentation, possibly by  an interaction with  the composition  of the gastro- intestinal 
microbiota, may modulate SCFs and their epigenetic effects. 
 
Nutrition and the immune system 
Expression of Interleukin 8 and the IL23/IL17 pathway is pivotal in the development of 
chronic inflammation such as Crohn's disease (CD) or inflammatory Bowel disease.(Li et al., 
2004; McGovern et al., 2009)  
 
IL-8, a member of the CXC chemokine family, is an important activator and chemoattractant 
for neutrophils  is primarily regulated at the transcriptional level.  IL-8 was  shown to be 
affected by methylation of several CpG islands upstream from the promoter region as well as 
by histone modification. Compounds, taking part in DNA methylation pathways and histone 
acetylation such as folic acid, vitamin B12, genistein, zebularine and valproate seem to 
influence epigenetic modification and gene expression of the IL-8 gene in human CACO-2 
colon cancer cells.  
 
 By contrast to leukemic blasts, where IL-8 is activated by differentiation(Delaunay et al., 
2008), immune activated transcription of IL-8 gene may be silenced after differentiation of 
cells from solid tumors such as breast cancer (Chavey et al., 2008) through histone 
deacetylation by elements located outside of the immediate 5´flanking region. 
The commensal microflora regulates the local expansion of CD4 T cells producing 
proinflammatory cytokines including IL-17 (Th17 cells) in the colonic lamina propria. (Niess 
et al., 2008)  TH cells, which produce IL-17 and IL-17F, two highly homologous cytokines 
whose genes are located in the same chromosomal region have been recently identified to 
promote tissue inflammation. In these cells Histone H3 acetylation and Lysine 4 tri-
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methylation were specifically associated with IL-17 and IL-17F gene promoters. (Akimzhanov 
et al., 2007) 
As natural food compounds and diets have been shown to modify the epigenetic regulation 
of these expression of these mediators (Kikuno et al., 2008; Romier et al., 2008) dietary 
strategies might be a possibility in modulating inflammatory diseases.  
Nutrition and aging  
Hereditary disposition, environmental elements, individual lifestyle and nutritional factors 
are known to interact with the aging process. These impacts on the aging-process can be 
divided in intrinsic and extrinsic factors. Intrinsic aging (cellular aging) mainly depends on 
individual hereditary background. Extrinsic aging is generated by external factors like 
smoking, excessive alcohol consumption and poor nutrition. During aging, epigenetic 
changes occur, for instance global DNA demethylation decrease contrasting to a CpG island 
hypermethylation.Progressive loss of global methylation during aging caused by passive 
demethylation is probably due to increasing DNMT1 enzyme inefficiency. Epigenetic changes 
can be seen as important determinants of cellular senescence and organism aging. Sirtuins 
take part in various cellular developments like chromatin remodelling, mitosis, life-span 
duration and are furthermore involved in the regulation of gene expression, insulin secretion 
and DNA repair. Since NAD is one of the critical molecules involved in many metabolic 
pathways, sirtuins activity is NAD(+) dependent and sirtuins control the activity of many 
other proteins involved in cell growth, it was suggested that sirtuins are involved in the 
elongation of life-span mediated by caloric restriction. Indeed, in mammals, caloric 
restriction decreases the incidence or delays the onset of age-associated diseases including 
cardiovascular diseases, cancer, and osteoporosis as well as neurodegenerative diseases. 
SIRT1 is known to be down regulated in senescent cells and during aging. Transcription 
factors like p53, p73, NF-KB, E2F1, p300 and others are also shown to be SIRT1 substrates, 
suggesting an oncogenetic potential for SIRT 1. In an ongoing process more and more sirtuin 
inhibitors are being discovered. Recent detections are sirtinol, cambinol, dihydrocoumarin 
and indole, coumarin and indoles being natural food compounds. Coumarin can be found in 
dates, dihydrocoumarin naturally in sweet clover and synthetically manufactured in foods 
and cosmetics. Indole is produced by intestinal bacteria as product of tryptophan 
degradation. Early findings about this novel class of HDACs are encouraging. Even more 
intensive research will be necessary to clarify connections between sirtuins, nutrition, aging 
and cancer genesis. 
It has been suggested that sirtuins may be involved in the elongation of life-span mediated 
by caloric restriction transcription factors, such as p53, p73, NF-KB, E2F1, p300 and others 
are shown to be SIRT1 substrates. Currently sirtuin inhibitors from natural compounds are 
being discovered (Akkermans et al., 2007; Kwon et al., 1998). Intensive research will be 
necessary to clarify any connections between sirtuins, nutrition, aging and cancer genesis. 
 
 
 
 
PUBLICATIONS 78 
 
Conclusion  
Epigenetic mechanisms contribute to the control of gene expression as a result of 
environmental signals due to their inherent malleability. Considerable evidence suggests 
that nutritional imbalance and metabolic disturbances during critical time windows of 
development, may have a persistent effect on the health of the concerned individulas and 
may even be transmitted to the next generation. For example, in addition to a "thrifty 
genotype" inheritance, individuals with obesity, type 2 diabetes, and metabolic syndrome 
with an increased risk of cardiovascular diseases may have suffered improper ”epigenetic 
programming" during their fetal/postnatal development due to maternal inadequate 
nutrition and metabolic disturbances and also during their lifetime, that could even be 
transmitted to the next generation(s), (Asim K Duttaroy, Evolution, Epigenetics, and 
Maternal Nutrition, Darwins Day Celebration, 2006). 
The balance between genetic and epigenetic impacts in development of malignancy is 
therefore changing from childhood to later age. Whereas e.g. the majority of childhood 
tumors are associated with an inherited genetic or epigenetic (e.g., imprinted) burden, this 
balance shifts in favor of acquired epigenetic and genetic hits in tumors of adults and elderly 
(Haslberger et al., 2006) ( Fig .3).  
 
As predicted by Rupert Riedl working with the so-called “General Systems Theory” the 
evolution of complex adaptation requires a match between the functional relationships of 
the phenotypic characters and their genetic representation [60]. Regarding to Riedl 
“evolvability” results from such a match. If the epigenetic regulation of gene expression 
"imitates" the functional organization of the traits then the improvement by mutation and 
selection is facilitated. Riedl predicts that the evolution of the genetic representation of 
phenotypic characters tends to favor those representations which imitate the functional 
organization of the characters. Imitation means that complexes of functionally related 
characters shall be "coded" as developmentally integrated characters but coded 
independently of functionally distinct character complexes (Wagner and Laubichler, 2004). 
 
Epigenetic mechanisms thus appear as a machinery of recursive feedback which determines 
the average rate of change of characters at all levels from molecules to cells, organisms and 
their environment(Haslberger et al., 2006). A better description of role of the epigenetic 
machinery in the interaction between hereditary and environmental interactions will also 
add to our understanding of evolution and an improved, individual and preventive health 
care system.  
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7.3. Abstracts for poster presentations 
7.3.1. 2nd Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN), 
Geneva, Oct. 6-8 2008 
 
Natural Food Compounds Affect DNA Methyltransferases, Promoter Methylation and 
Gene Expression of Immune Relevant Genes in the CACO2 Cell-Line 
 
A.G. Haslberger, R. Thaler, V. Sagl, E. Rudolf 
 
University of Vienna, Department for Nutritional Sciences, Vienna, Austria 
 
Natural compounds of foods are under investigation for their effects on the epigenetic 
control of the expression of genes. This study analyzes the impact of folic acid, vitamin B12 
and genistein on the expression of DNA-methyltransferases (Dnmt), histonedeacetylase-2 
(HDAC-2) and selected genes under discussion for a potential epigenetic control (IL-8, E-
Cadherin ). Analysis of gene expression was performed in CACO-2 cell-line after 48 h 
incubation using Sybr Green rt-PCR. For DNA global methylation ELISA technique was used; 
gene promoter methylation was analyzed by Bisulfite Genomic Sequencing PCR (BSP) and 
Methylation Specific PCR (MSP). Incubation of CACO-2 cells with the Dnmt-inhibitor 
zebularine increased expression of E-Cadherin. The methyldonator folic acid and the 
methioninesynthetase co-factor vitamin B12 increased the expression of Il-8 as well as the 
expression of DNMT3a and DNMT3b.Also the HDAC inhibitor Valproate substantially 
stimulated gene expression of IL-8. In correspondence with gene expression Zebularine 
could be demonstrated to decrease CpG methylation of promoter regions such as of E-
Cadherin as well as DNA-global methylation (-30%). Methylation of CpGs upstream the the 
IL-8 gene correlated with IL-8 gene expression. A significant increase of the methylation of 
these sites were seen after treatment with folic acid and vitamin B12. These experiences 
support evidences for effects of dietary factors on an epigenetic control of expression of 
genes including genes of the I.S. and encourage strategies for a targeted dietary support in 
the treatment of immune related diseases with epigenetic control. 
 
published in: Journal of Nutrigenetics and Nutrigenomics 2008;1:1–51 
  
85 PUBLICATIONS 
 
7.3.2. NuGOweek 2009, Montecatini Terme, Aug. 31-Sep. 3 2009 
 
EPIGENETIC REGULATION OF IL-8 AND E-CADHERIN GENE EXPRESSION BY BUTYRATE, FOLIC 
ACID, AND GENISTEIN INCLUDES DNA-METHYLATION AND HISTONE ACETYLATION  
E. Aumueller, A. Gnauck, C. Berner, P. Klein, A. G. Haslberger 
Department of Nutrition, University of Vienna 
Alexander.haslberger@univie.ac.at 
 
The expression of IL-8 and E-Cadherin regulates the interactions between immune cells and 
epithelia in the GI-tract involving epigenetic mechanisms. Because of the epigenetic 
activities of the SCF butyrate, produced by intestinal microbiota, as well as genistein and 
folic acid we analyzed effects on histone acetylation and DNA-methylation on the expression 
of IL-8 and E-Cadh. 
 
Gene expression was analyzed by real time PCR, DNA-methylation by Methylation Specific 
PCR (MSP), bisulfite sequencing PCR (BSP) and histone acetylation by Chromatin 
immunoprecipitation in the CACO-2 cell line model. 
 
IL-8 and E-Cadh expression was increased by genistein, butyrate, folic acid and the DNA 
methyltransferase inhibitor zebularine.  Whereas zebularine decreased DNA methylation of 
E-Cadh and IL-8 (on the sites -1342 and -1412), butyrate enhanced the histone acetylation 
on H3 lysine 9 at IL-8. Genistein and butyrate also stimulated the apoptose relevant 
caspase3. Changes in butyrate producing GI-microbiota (Clostridium cluster IX and XIVa) 
were found due to nutrition. 
 
As the levels of genistein, folic acid, and butyrate in the GI-tract can be modulated by 
nutrition, nutritional concepts may be feasible to interfere with epigenetic mechanisms in 
inflammatory GI diseases. 
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7.3.3. Epigenetic World Congress, Berlin, Sep. 17-18 2009 
 
Food ingredients modulate epigenetic control of expression of estrogen receptor and 
tumor suppressor genes 
 
Aumueller E.1, Berner C.1, Gnauck A.1, Just A.2, Haslberger AG1 
 
1University of Vienna 
Department for nutritional sciences 
 
2Medical University of Vienna 
Department of Obestrics and Gynecology 
 
 
Estrogen receptor alpha (ESR1) plays vital roles in the development and progression of 
breast cancer and metabolic disorders. The expression is known to be regulated by 
epigenetic mechanisms. Also the tumor suppressor genes P15 and P16 are aberrantly 
methylated in several cancer types. 
To evaluate possible effects of dietary compounds on the epigenetic gene expression Caco2-
cells were treated with butyrate, resveratrol, genistein, zebularine, folic acid, chrysin, and 
EGCG, which are known to have estrogenic or epigenetic effects. Gene expression was 
analyzed for ESR1, P15, and P16 by quantitative real-time-PCR. Methylation of specific CpG-
sites was determined by methylation-specific PCR. 
Treatment with genistein, folate, EGCG, and resveratrol increased and zebularine and 
chrysin decreased methylation of ESR1. P15 methylation was enhanced by genistein and 
folate and decreased by chrysin, zebularine, butyrate, EGCG, and resveratrol. Treatment 
with folate resulted in P16 hypermethylation whereas all other agents resulted in 
hypomethylation of this gene. Changes in methylation corresponded with altered gene 
expression. In contrast to CACO cells human blood cells show less methylation on the 
investigated genes. These results suggest that food ingredients may influence epigenetic 
modification of cancer relevant gene expression and might be considered for supplemental 
treatment and prevention. 
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7.3.4. 19th International Congress of Nutrition, Bangkok, Oct. 4-9 2009 
 
REGULATION OF IL-8 AND IL-17 EXPRESSION BY BUTYRATE, FOLIC ACID, AND GENISTEIN 
INCLUDES DNA METHYLATIONAND HISTONE ACETYLATION 
E. Aumueller, C. Berner, A. Gauck, P. Klein, A. G. Haslberger 
Department of Nutrition, University of Vienna 
 
IL-8 and IL-17 regulate interactions between immune cells and epithelia in the GI-tract, 
involving epigenetic mechanisms. Because of the epigenetic activities of the SCF (short chain 
fatty acid) butyrate, produced by intestinal microbiota, genistein and folic acid we analyzed 
effects on histone acetylation and DNA-methylation on interleukin-8 and -17 genes. 
 
We analyzed gene expression by real time PCR, DNA-methylation by bisulfite sequencing 
PCR, and histone acetylation by Chromatin immunoprecipitation in the CACO-2 cell line 
model. 
 
IL-8 and IL-17 expression was increased by genistein, butyrate, and folic acid. Folic acid 
stimulated the IL-8-DNA-methylation on the sites -1342 and -1412. Butyrate stimulated the 
histone acetylation on H3 lysine 9 at IL-8. Genistein and butyrate also stimulated apoptosis 
relevant caspase-3. Changes in butyrate producing GI-microbiota (Clostridium cluster IX and 
XIVa) were found due to nutrition. 
 
As the levels of genistein, folic acid, and butyrate in the GI-tract can be influenced by 
nutrition, nutritional concepts may be feasible to interfere with IL-8 and IL-17 expression in 
inflammatory GI diseases. 
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8. PROTOCOLS 
8.1. RNeasy® Lipid Tissue Handbook (Qiagen) 
1. If using the TissueLyser, add one stainless steel bead (5 mm mean diameter) per 2 ml 
microcentrifuge tube (not supplied). If working with tissues that are not stabilized in 
RNAlater RNA Stabilization Reagent, place the tubes on dry ice. 
2. Excise the tissue sample from the animal or remove it from storage. Determine the 
amount of tissue. Do not use more than 100 mg. Proceed immediately to step 3. 
Weighing tissue is the most accurate way to determine the amount. If the tissue sample 
was stored in RNAlater RNA Stabilization Reagent, remove it from the reagent using 
forceps and be sure to remove any crystals that may have formed. RNA in harvested 
tissues is not protected until the tissues are treated with RNAlater RNA Stabilization 
Reagent, flash-frozen, or disrupted and homogenized in step 3. Frozen tissues should not 
be allowed to thaw during handling. The relevant procedures should be carried out as 
quickly as possible. 3. Disrupt the tissue and homogenize the lysate using either the 
TissueRupter (follow step 3a) or TissueLyser (follow step 3b). See “Disrupting and 
homogenizing starting material”, page 12, for more details on disruption and 
homogenization. 
Note: Incomplete homogenization leads to significantly reduced RNA yields and can cause 
clogging of the RNeasy spin column. Homogenization with the TissueRupter or 
TissueLyser generally results in higher RNA yields than with other methods. 
3a. Disruption and homogenization using the TissueRuptor: 
■ Place the tissue in a suitably sized vessel containing 1 ml QIAzol Lysis Reagent. 
Note: Use a suitably sized vessel with sufficient extra headspace to accommodate 
foaming, which may occur during homogenization. Generally, round-bottomed tubes 
allow more efficient disruption and homogenization than conical-bottomed tubes. 
■ Place the tip of the disposable probe into the vessel and operate the TissueRuptor at full 
speed until the lysate is uniformly homogeneous (usually 20–40 s). Proceed to step 4. 
Note: To avoid damage to the TissueRuptor and disposable probe during operation, make 
sure the tip of the probe remains submerged in the buffer. Foaming may occur during 
homogenization, especially of brain tissue. If this occurs, let the homogenate stand at 
room temperature for 2–3 min until the foam subsides before continuing with the 
procedure. 
3b. Disruption and homogenization using the TissueLyser: 
■ Place the tissues in the tubes prepared in step 1. 
■ If the tubes were stored on dry ice, place them at room temperature. Then immediately 
add 1 ml QIAzol Lysis Reagent per tube. 
■ Place the tubes in the TissueLyser Adapter Set 2 x 24. 
■ Operate the TissueLyser for 2 min at 20 Hz. 
The time depends on the tissue being processed and can be extended until the tissue is 
completely homogenized. 
■ Rearrange the collection tubes so that the outermost tubes are innermost and the 
innermost tubes are outermost. Operate the TissueLyser for another 2 min at 20 Hz. 
Rearranging the tubes allows even homogenization. 
89 PROTOCOLS 
 
■ Carefully pipet the lysates into new microcentrifuge tubes (not supplied). 
Proceed to step 4. Do not reuse the stainless steel beads. 
4. Place the tube containing the homogenate on the benchtop at room temperature (15–
25°C) for 5 min. 
This step promotes dissociation of nucleoprotein complexes. 
5. Add 200 μl chloroform. Securely cap the tube containing the homogenate, and shake it 
vigorously for 15 s. 
Thorough mixing is important for subsequent phase separation. 
6. Place the tube containing the homogenate on the benchtop at room temperature for 2–3 
min. 
7. Centrifuge at 12,000 x g for 15 min at 4°C. After centrifugation, heat the centrifuge to 
room temperature (15–25°C) if the same centrifuge will be used in the later steps of this 
procedure. After centrifugation, the sample separates into 3 phases: an upper, colorless, 
aqueous phase containing RNA; a white interphase; and a lower, red, organic phase. For 
tissues with an especially high fat content, an additional, clear phase may be visible below 
the red, organic phase. The volume of the aqueous phase should be approximately 600 μl. 
8. Transfer the upper, aqueous phase to a new tube (not supplied). Add 1 volume (usually 
600 μl) of 70% ethanol, and mix thoroughly by vortexing. Do not centrifuge. Proceed 
immediately to step 9. 
Note: The volume of lysate may be less than 600 μl due to loss during homogenization 
and centrifugation. 
Precipitates may be visible after addition of ethanol. Resuspend precipitates completely 
by vigorous shaking, and proceed immediately to step 9. 
9. Transfer up to 700 μl of the sample to an RNeasy Mini spin column placed in a 2 ml 
collection tube (supplied). Close the lid gently, and centrifuge for 15 s at 8000 x g 
(10,000 rpm) at room temperature (15–25°C). Discard the flow-through. 
Reuse the collection tube in step 10. 
10. Repeat step 9 using the remainder of the sample. Discard the flow-through. 
Reuse the collection tube in step 11. 
Optional: If performing optional on-column DNase digestion (see “Important points 
before starting”), follow steps C1–C4 (page 32) after performing this step. 
11. Add 700 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge 
for 15 s at _8000 x g (_10,000 rpm) to wash the membrane. Discard the flow-through. 
Reuse the collection tube in step 12. 
After centrifugation, carefully remove the RNeasy spin column from the collection tube so 
that the column does not contact the flow-through. Be sure to empty the collection tube 
completely. 
Skip this step if performing optional on-column DNase digestion (page 32). 
12. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge for 
15 s at 8000 x g (10,000 rpm) to wash the membrane. Discard the flow-through. 
Reuse the collection tube in step 13. 
Note: Buffer RPE is supplied as a concentrate. Ensure that ethanol is added to Buffer RPE 
before use (see “Things to do before starting”, page 15). 
13. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge for 
2 min at 8000 x g (10,000 rpm) to wash the membrane. The long centrifugation dries the 
spin column membrane, ensuring that no ethanol is carried over during RNA elution. 
Residual ethanol may interfere with downstream reactions. 
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Note: After centrifugation, carefully remove the RNeasy spin column from the collection 
tube so that the column does not contact the flow-through. Otherwise, carryover of 
ethanol will occur. 
14. Optional: Place the RNeasy spin column in a new 2 ml collection tube (supplied), and 
discard the old collection tube with the flow-through. Close the lid gently, and centrifuge 
at full speed for 1 min. 
Perform this step to eliminate any possible carryover of Buffer RPE, or if residual flow-
through remains on the outside of the RNeasy spin column after step 13. 
15. Place the RNeasy spin column in a new 1.5 ml collection tube (supplied). Add 30–50 μl 
RNase-free water directly to the spin column membrane. Close the lid gently. To elute the 
RNA, centrifuge for 1 min at 8000 x g (10,000 rpm). 
16. Repeat step 15 using another volume of RNase-free water, or using the eluate from step 
15 (if high RNA concentration is required). 
Reuse the collection tube from step 15. 
If using the eluate from step 15, the RNA yield will be 15–30% less than that obtained using a 
second volume of RNase-free water, but the final RNA concentration will be higher. 
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8.2. QIAamp® DNA Mini and Blood Mini Handbook (Qiagen) 
1. Pipet 20 μl QIAGEN Protease (or proteinase K) into the bottom of a 1.5 ml microcentrifuge 
tube. 
2. Add 200 μl sample to the microcentrifuge tube. Use up to 200 μl whole blood, plasma, 
serum, buffy coat, or body fluids, or up to 5 x 106 lymphocytes in 200 μl PBS. 
If the sample volume is less than 200 μl, add the appropriate volume of PBS. QIAamp Mini 
spin columns copurify RNA and DNA when both are present in the sample. RNA may 
inhibit some downstream enzymatic reactions, but not PCR. If RNA-free genomic DNA is 
required, 4 μl of an RNase A stock solution (100 mg/ml) should be added to the sample 
before addition of Buffer AL. 
Note: It is possible to add QIAGEN Protease (or proteinase K) to samples that have 
already been dispensed into microcentrifuge tubes. In this case, it is important to ensure 
proper mixing after adding the enzyme. 
3. Add 200 μl Buffer AL to the sample. Mix by pulse-vortexing for 15 s. 
In order to ensure efficient lysis, it is essential that the sample and Buffer AL are mixed 
thoroughly to yield a homogeneous solution. If the sample volume is larger than 200 μl, 
increase the amount of QIAGEN Protease (or proteinase K) and Buffer AL proportionally; 
for example, a 400 μl sample will require 40 μl QIAGEN Protease (or proteinase K) and 
400 μl Buffer AL. If sample volumes larger than 400 μl are required, use of QIAamp DNA 
Blood Midi or Maxi Kits is recommended; these can process up to 2 ml or up to 10 ml of 
sample, respectively. 
Note: Do not add QIAGEN Protease or proteinase K directly to Buffer AL. 
4. Incubate at 56°C for 10 min. 
DNA yield reaches a maximum after lysis for 10 min at 56°C. Longer incubation times have 
no effect on yield or quality of the purified DNA. 
5. Briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from the inside of the 
lid. 
6. Add 200 μl ethanol (96–100%) to the sample, and mix again by pulse-vortexing for 15 s. 
After mixing, briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from the 
inside of the lid. 
If the sample volume is greater than 200 μl, increase the amount of ethanol 
proportionally; for example, a 400 μl sample will require 400 μl of ethanol. 
7. Carefully apply the mixture from step 6 to the QIAamp Mini spin column (in a 2 ml 
collection tube) without wetting the rim. Close the cap, and centrifuge at 6000 x g 
(8000 rpm) for 1 min. Place the QIAamp Mini spin column in a clean 2 ml collection tube 
(provided), and discard the tube containing the filtrate. 
Close each spin column in order to avoid aerosol formation during centrifugation. 
Centrifugation is performed at 6000 x g (8000 rpm) in order to reduce noise. 
Centrifugation at full speed will not affect the yield or purity of the DNA. If the lysate has 
not completely passed through the column after centrifugation, centrifuge again at higher 
speed until the QIAamp Mini spin column is empty. 
Note: When preparing DNA from buffy coat or lymphocytes, centrifugation at full speed is 
recommended to avoid clogging. 
8. Carefully open the QIAamp Mini spin column and add 500 μl Buffer AW1 without wetting 
the rim. Close the cap and centrifuge at 6000 x g (8000 rpm) for 1 min. Place the QIAamp 
Mini spin column in a clean 2 ml collection tube (provided), and discard the collection 
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tube containing the filtrate. 
It is not necessary to increase the volume of Buffer AW1 if the original sample volume is 
larger than 200 μl. 
9. Carefully open the QIAamp Mini spin column and add 500 μl Buffer AW2 without wetting 
the rim. Close the cap and centrifuge at full speed (20,000 x g; 14,000 rpm) for 3 min. 
10. Recommended: Place the QIAamp Mini spin column in a new 2 ml collection tube (not 
provided) and discard the old collection tube with the filtrate. Centrifuge at full speed for 
1 min. 
This step helps to eliminate the chance of possible Buffer AW2 carryover. 
11. Place the QIAamp Mini spin column in a clean 1.5 ml microcentrifuge tube (not 
provided), and discard the collection tube containing the filtrate. Carefully open the 
QIAamp Mini spin column and add 200 μl Buffer AE or distilled water. Incubate at room 
temperature (15–25°C) for 1 min, and then centrifuge at 6000 x g (8000 rpm) for 1 min. 
Incubating the QIAamp Mini spin column loaded with Buffer AE or water for 5 min at 
room temperature before centrifugation generally increases DNA yield. A second elution 
step with a further 200 μl Buffer AE will increase yields by up to 15%. Volumes of more 
than 200 μl should not be eluted into a 1.5 ml microcentrifuge tube because the spin 
column will come into contact with the eluate, leading to possible aerosol formation 
during centrifugation. Elution with volumes of less than 200 μl increases the final DNA 
concentration in the eluate significantly, but slightly reduces the overall DNA yield (see 
Table 5, page 26). For samples containing less than 1 μg of DNA, elution in 50 μl Buffer AE 
or water is recommended. Eluting with 2 x 100 μl instead of 1 x 200 μl does not increase 
elution efficiency. 
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8.3. QIAquick® Spin Handbook QIAquick PCR Purification Kit (Qiagen) 
1. Add 5 volumes of Buffer PB to 1 volume of the PCR sample and mix. It is not necessary to 
remove mineral oil or kerosene. 
For example, add 500 μl of Buffer PB to 100 μl PCR sample (not including oil). 
2. If pH indicator I has beein added to Buffer PB, check that the color of the mixture is 
yellow. 
If the color of the mixture is orange or violet, add 10 μl of 3 M sodium acetate, pH 5.0, 
and mix. The color of the mixture will turn to yellow. 
3. Place a QIAquick spin column in a provided 2 ml collection tube. 
4. To bind DNA, apply the sample to the QIAquick column and centrifuge for 30–60 s. 
5. Discard flow-through. Place the QIAquick column back into the same tube. 
Collection tubes are re-used to reduce plastic waste. 
6. To wash, add 0.75 ml Buffer PE to the QIAquick column and centrifuge for 30–60 s. 
7. Discard flow-through and place the QIAquick column back in the same tube. Centrifuge 
the column for an additional 1 min. 
IMPORTANT: Residual ethanol from Buffer PE will not be completely removed unless the 
flow-through is discarded before this additional centrifugation. 
8. Place QIAquick column in a clean 1.5 ml microcentrifuge tube. 
9. To elute DNA, add 50 μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water (pH 7.0–8.5) to the 
center of the QIAquick membrane and centrifuge the column for 1 min. Alternatively, for 
increased DNA concentration, add 30 μl elution buffer to the center of the QIAquick 
membrane, let the column stand for 1 min, and then centrifuge. 
IMPORTANT: Ensure that the elution buffer is dispensed directly onto the QIAquick 
membrane for complete elution of bound DNA. The average eluate volume is 48 μl from 
50 μl elution buffer volume, and 28 μl from 30 μl elution buffer. Elution efficiency is 
dependent on pH. The maximum elution efficiency is achieved between pH 7.0 and 8.5. 
When using water, make sure that the pH value is within this range, and store DNA at –
20°C as DNA may degrade in the absence of a buffering agent. The purified DNA can also 
be eluted in TE buffer (10 mM Tris·Cl, 1 mM EDTA, pH 8.0), but the EDTA may inhibit 
subsequent enzymatic reactions.
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